<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Johnson &amp; Johnson - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"Xph0gwpAMMQAAuNEeNsAAACK","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Johnson_\u0026_Johnson","wgTitle":"Johnson \u0026 Johnson","wgCurRevisionId":950813906,"wgRevisionId":950813906,"wgArticleId":166826,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Johnson_\u0026_Johnson","wgRelevantArticleId":166826,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":
!0,"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCoordinates":{"lat":40.49861111111111,"lon":-74.44361111111111},"wgWikibaseItemId":"Q333718","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":
!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.27"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/9/99/JohnsonJohnson_HQ_building.jpg/1200px-JohnsonJohnson_HQ_building.jpg"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Johnson_%26_Johnson"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Johnson_Johnson rootpage-Johnson_Johnson stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Johnson+%26+Johnson" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Johnson+%26+Johnson" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Johnson &amp; Johnson</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Johnson_%26_Johnson" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Johnson+%26+Johnson" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0"><div role="note" class="hatnote navigation-not-searchable">Not to be confused with <a href="/wiki/S._C._Johnson_%26_Son" title="S. C. Johnson &amp; Son">S. C. Johnson &amp; Son</a>.</div>

<p class="mw-empty-elt">

</p>
<p><b>Johnson &amp; Johnson</b> is an American <a href="/wiki/Multinational_corporation" title="Multinational corporation">multinational corporation</a> founded in 1886 that develops medical devices, pharmaceutical and consumer packaged goods. Its common stock is a component of the <a href="/wiki/Dow_Jones_Industrial_Average" title="Dow Jones Industrial Average">Dow Jones Industrial Average</a> and the company is ranked No. 37 on the 2018 <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a> list of the largest United States corporations by total revenue. J&amp;J is one of the <a href="/wiki/List_of_public_corporations_by_market_capitalization" title="List of public corporations by market capitalization">world's most valuable companies</a>.
</p><table class="infobox vcard" style="width:22em"><caption class="fn org">Johnson &amp; Johnson</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:JohnsonandJohnsonLogo.svg" class="image"><img alt="JohnsonandJohnsonLogo.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/22/JohnsonandJohnsonLogo.svg/220px-JohnsonandJohnsonLogo.svg.png" decoding="async" width="220" height="42" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/22/JohnsonandJohnsonLogo.svg/330px-JohnsonandJohnsonLogo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/22/JohnsonandJohnsonLogo.svg/440px-JohnsonandJohnsonLogo.svg.png 2x" data-file-width="400" data-file-height="76"></a></td></tr><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:JohnsonJohnson_HQ_building.jpg" class="image"><img alt="JohnsonJohnson HQ building.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/99/JohnsonJohnson_HQ_building.jpg/250px-JohnsonJohnson_HQ_building.jpg" decoding="async" width="250" height="185" data-file-width="1671" data-file-height="1237"></a><div>J&amp;J headquarters at One Johnson &amp; Johnson Plaza in <a href="/wiki/New_Brunswick,_New_Jersey" title="New Brunswick, New Jersey">New Brunswick</a>, <a href="/wiki/New_Jersey" title="New Jersey">New Jersey</a></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:JNJ">JNJ</a><br><a href="/wiki/Dow_Jones_Industrial_Average" title="Dow Jones Industrial Average">DJIA Component</a><br><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100 Component</a><br><a href="/wiki/S%26P_500_Index" title="S&amp;P 500 Index">S&amp;P 500 Component</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US4781601046">US4781601046</a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">Pharmaceutical</a><br><a href="/wiki/Medical_devices" class="mw-redirect" title="Medical devices">Medical devices</a><br><a href="/wiki/Consumer_products" class="mw-redirect" title="Consumer products">Consumer products</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">January 1886<span class="noprint">; 134 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1886-01</span>)</span><br><a href="/wiki/New_Brunswick,_New_Jersey" title="New Brunswick, New Jersey">New Brunswick, New Jersey</a>, United States</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founders</th><td class="agent" style="line-height: 1.35em;"><a href="/wiki/Robert_Wood_Johnson_I" title="Robert Wood Johnson I">Robert Wood Johnson I</a><br><a href="/wiki/James_Wood_Johnson" title="James Wood Johnson">James Wood Johnson</a><br><a href="/wiki/Edward_Mead_Johnson" title="Edward Mead Johnson">Edward Mead Johnson</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;">One Johnson &amp; Johnson Plaza, <div style="display: inline;" class="locality"><a href="/wiki/New_Brunswick,_New_Jersey" title="New Brunswick, New Jersey">New Brunswick, New Jersey</a></div>, <div style="display: inline;" class="country-name"><a href="/wiki/United_States" title="United States">U.S.</a></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Area served</div></th><td style="line-height: 1.35em;">Worldwide</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><a href="/wiki/Alex_Gorsky" title="Alex Gorsky">Alex Gorsky</a> <span style="font-size:85%;">(<a href="/wiki/Chairman" class="mw-redirect" title="Chairman">Chairman</a> and <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a>)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;"><a href="/wiki/Johnson_%26_Johnson#Products" title="Johnson &amp; Johnson">See list of Johnson &amp; Johnson products</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap"><a href="/wiki/United_States_dollar" title="United States dollar">US$</a>82.059 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-10-K_2019_1-0" class="reference"><a href="#cite_note-10-K_2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$17.33 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-10-K_2019_1-1" class="reference"><a href="#cite_note-10-K_2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$15.119 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-10-K_2097_2-0" class="reference"><a href="#cite_note-10-K_2097-2">[2]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$157.73 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-10-K_2019_1-2" class="reference"><a href="#cite_note-10-K_2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$59.47 billion</span> <span style="font-size:85%;">(2019)</span><sup id="cite_ref-10-K_2019_1-3" class="reference"><a href="#cite_note-10-K_2019-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;"><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> 132,200 <span style="font-size:85%;">(2019)</span><sup id="cite_ref-3" class="reference"><a href="#cite_note-3">[3]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Subsidiary" title="Subsidiary">Subsidiaries</a></th><td style="line-height: 1.35em;"><a href="/wiki/Janssen_Pharmaceutica" title="Janssen Pharmaceutica">Janssen Pharmaceutica</a><br><a href="/wiki/McNeil_Consumer_Healthcare" title="McNeil Consumer Healthcare">McNeil Consumer Healthcare</a><br><a href="/wiki/Acuvue" title="Acuvue">Vistakon</a><sup id="cite_ref-4" class="reference"><a href="#cite_note-4">[4]</a></sup><br><a href="/wiki/Neutrogena" title="Neutrogena">Neutrogena</a><br><a href="/wiki/DePuy" title="DePuy">DePuy</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="https://www.jnj.com">www<wbr></wbr>.jnj<wbr></wbr>.com</a></span></td></tr></tbody></table><p>Johnson &amp; Johnson is headquartered in <a href="/wiki/New_Brunswick,_New_Jersey" title="New Brunswick, New Jersey">New Brunswick, New Jersey</a>, the consumer division being located in <a href="/wiki/Skillman,_New_Jersey" title="Skillman, New Jersey">Skillman, New Jersey</a>. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson &amp; Johnson had worldwide sales of $70.1 billion during calendar year 2015.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">[5]</a></sup>
Johnson &amp; Johnson's brands include numerous household names of medications and <a href="/wiki/First_aid" title="First aid">first aid</a> supplies. Among its well-known consumer products are the <a href="/wiki/Band-Aid" title="Band-Aid">Band-Aid</a> Brand line of bandages, <a href="/wiki/Tylenol_(brand)" title="Tylenol (brand)">Tylenol</a> medications, <a href="/wiki/Johnson%27s_Baby" title="Johnson's Baby">Johnson's Baby</a> products, <a href="/wiki/Neutrogena" title="Neutrogena">Neutrogena</a> <a href="/wiki/Cosmetics" title="Cosmetics">skin and beauty products</a>, <a href="/wiki/Clean_%26_Clear" title="Clean &amp; Clear">Clean &amp; Clear</a> facial wash and <a href="/wiki/Acuvue" title="Acuvue">Acuvue</a> <a href="/wiki/Contact_lens" title="Contact lens">contact lenses</a>.
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a>
<ul><li class="toclevel-2 tocsection-2"><a href="#Foundation_and_early_history"><span class="tocnumber">1.1</span> <span class="toctext">Foundation and early history</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#1943-44:_Credo_and_Going_Public"><span class="tocnumber">1.2</span> <span class="toctext">1943-44: Credo and Going Public</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#1959:_McNeil_Consumer_Healthcare"><span class="tocnumber">1.3</span> <span class="toctext">1959: McNeil Consumer Healthcare</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#1959:_Cilag"><span class="tocnumber">1.4</span> <span class="toctext">1959: Cilag</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#1961:_Janssen_Pharmaceuticals"><span class="tocnumber">1.5</span> <span class="toctext">1961: Janssen Pharmaceuticals</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#1998:_DePuy"><span class="tocnumber">1.6</span> <span class="toctext">1998: DePuy</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#1999:_Janssen_Biotech,_Inc."><span class="tocnumber">1.7</span> <span class="toctext">1999: Janssen Biotech, Inc.</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Ethicon,_Inc."><span class="tocnumber">1.8</span> <span class="toctext">Ethicon, Inc.</span></a>
<ul><li class="toclevel-3 tocsection-10"><a href="#Ethicon_Endo-Surgery,_Inc."><span class="tocnumber">1.8.1</span> <span class="toctext">Ethicon Endo-Surgery, Inc.</span></a></li>
</ul></li>
<li class="toclevel-2 tocsection-11"><a href="#Actelion"><span class="tocnumber">1.9</span> <span class="toctext">Actelion</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Johnson_&amp;_Johnson_Vision_Care,_Inc."><span class="tocnumber">1.10</span> <span class="toctext">Johnson &amp; Johnson Vision Care, Inc.</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#2010_onwards"><span class="tocnumber">1.11</span> <span class="toctext">2010 onwards</span></a>
<ul><li class="toclevel-3 tocsection-14"><a href="#Structure"><span class="tocnumber">1.11.1</span> <span class="toctext">Structure</span></a></li>
</ul></li>
</ul></li>
<li class="toclevel-1 tocsection-15"><a href="#Finance"><span class="tocnumber">2</span> <span class="toctext">Finance</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Corporate_governance"><span class="tocnumber">3</span> <span class="toctext">Corporate governance</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#Chairmen"><span class="tocnumber">4</span> <span class="toctext">Chairmen</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#Headquarters_and_the_New_Brunswick_gentrification"><span class="tocnumber">5</span> <span class="toctext">Headquarters and the New Brunswick gentrification</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#Products"><span class="tocnumber">6</span> <span class="toctext">Products</span></a>
<ul><li class="toclevel-2 tocsection-20"><a href="#Pharmaceuticals"><span class="tocnumber">6.1</span> <span class="toctext">Pharmaceuticals</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Medical_devices"><span class="tocnumber">6.2</span> <span class="toctext">Medical devices</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Consumer_health"><span class="tocnumber">6.3</span> <span class="toctext">Consumer health</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-23"><a href="#Environmental_record"><span class="tocnumber">7</span> <span class="toctext">Environmental record</span></a></li>
<li class="toclevel-1 tocsection-24"><a href="#Recalls_and_litigation"><span class="tocnumber">8</span> <span class="toctext">Recalls and litigation</span></a>
<ul><li class="toclevel-2 tocsection-25"><a href="#1982_Chicago_Tylenol_murders"><span class="tocnumber">8.1</span> <span class="toctext">1982 Chicago Tylenol murders</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#2010_children's_product_recall"><span class="tocnumber">8.2</span> <span class="toctext">2010 children's product recall</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#2010_hip-replacement_recall"><span class="tocnumber">8.3</span> <span class="toctext">2010 hip-replacement recall</span></a></li>
<li class="toclevel-2 tocsection-28"><a href="#2010_Tylenol_recall"><span class="tocnumber">8.4</span> <span class="toctext">2010 Tylenol recall</span></a></li>
<li class="toclevel-2 tocsection-29"><a href="#Shareholders_lawsuit"><span class="tocnumber">8.5</span> <span class="toctext">Shareholders lawsuit</span></a></li>
<li class="toclevel-2 tocsection-30"><a href="#Illegal_marketing_of_Risperdal"><span class="tocnumber">8.6</span> <span class="toctext">Illegal marketing of Risperdal</span></a></li>
<li class="toclevel-2 tocsection-31"><a href="#Foreign_bribery"><span class="tocnumber">8.7</span> <span class="toctext">Foreign bribery</span></a></li>
<li class="toclevel-2 tocsection-32"><a href="#Consumer_fraud_settlements"><span class="tocnumber">8.8</span> <span class="toctext">Consumer fraud settlements</span></a></li>
<li class="toclevel-2 tocsection-33"><a href="#Use_of_the_Red_Cross_symbol"><span class="tocnumber">8.9</span> <span class="toctext">Use of the Red Cross symbol</span></a></li>
<li class="toclevel-2 tocsection-34"><a href="#Boston_Scientific_lawsuits"><span class="tocnumber">8.10</span> <span class="toctext">Boston Scientific lawsuits</span></a></li>
<li class="toclevel-2 tocsection-35"><a href="#Patent-infringement_case_against_Abbott"><span class="tocnumber">8.11</span> <span class="toctext">Patent-infringement case against Abbott</span></a></li>
<li class="toclevel-2 tocsection-36"><a href="#Vaginal_mesh_implants"><span class="tocnumber">8.12</span> <span class="toctext">Vaginal mesh implants</span></a></li>
<li class="toclevel-2 tocsection-37"><a href="#Baby_powder"><span class="tocnumber">8.13</span> <span class="toctext">Baby powder</span></a></li>
<li class="toclevel-2 tocsection-38"><a href="#Opioid_epidemic"><span class="tocnumber">8.14</span> <span class="toctext">Opioid epidemic</span></a>
<ul><li class="toclevel-3 tocsection-39"><a href="#Northeastern_Ohio_Settlement"><span class="tocnumber">8.14.1</span> <span class="toctext">Northeastern Ohio Settlement</span></a></li>
</ul></li>
</ul></li>
<li class="toclevel-1 tocsection-40"><a href="#See_also"><span class="tocnumber">9</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-41"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-42"><a href="#External_links"><span class="tocnumber">11</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<p>Johnson &amp; Johnson operates over 250 companies in what is termed "the Johnson &amp; Johnson family of companies".<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup> The company operates in three broad divisions; Consumer Healthcare, Medical Devices and Pharmaceuticals.
</p>
<table class="wikitable"><tbody><tr><th colspan="3"><small>Johnson &amp; Johnson Family of Companies</small>
</th></tr><tr><th>Consumer Healthcare<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup></th>
<th>Medical Devices<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">[8]</a></sup></th>
<th>Pharmaceuticals<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">[9]</a></sup></th></tr><tr><td>Baby Care<br>Skin &amp; Hair Care<br>Wound Care and Topicals<br>Oral Health Care<br>Women's Health<br>McNeil Consumer Healthcare<br>Over-The-Counter Medicines<br>Nutritionals</td>
<td><br>Biosense Webster<br><a href="/wiki/DePuy" title="DePuy">DePuy Synthes</a><br><a href="/wiki/Ethicon,_Inc." class="mw-redirect" title="Ethicon, Inc.">Ethicon, Inc.</a><br>Janssen Diagnostics BVBA<br>Johnson &amp; Johnson Vision Care, Inc.<br><br>Mentor</td>
<td><a href="/wiki/Janssen_Pharmaceutica" title="Janssen Pharmaceutica">Janssen</a><br>Janssen R&amp;D LLC<br>Janssen Healthcare Innovation<br>Janssen Pharmaceuticals Inc<br>Janssen Diagnostics<br><a href="/wiki/Janssen_Therapeutics" class="mw-redirect" title="Janssen Therapeutics">Janssen Therapeutics</a><br>Janssen Scientific Affairs<br>McNeil-PPC, Inc
</td></tr></tbody></table><h3 class="in-block"><span class="mw-headline" id="Foundation_and_early_history">Foundation and early history</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=2" title="Edit section: Foundation and early history" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tleft"><div class="thumbinner" style="width:182px;"><a href="/wiki/File:Robert-wood-johnson-i.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Robert-wood-johnson-i.jpg/180px-Robert-wood-johnson-i.jpg" decoding="async" width="180" height="232" class="thumbimage" data-file-width="768" data-file-height="988"></noscript><span class="lazy-image-placeholder" style="width: 180px;height: 232px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Robert-wood-johnson-i.jpg/180px-Robert-wood-johnson-i.jpg" data-alt="" data-width="180" data-height="232" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Robert-wood-johnson-i.jpg" class="internal" title="Enlarge"></a></div>Robert Wood Johnson</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Johnson_and_Johnson_corrosive_sublimate_cotton.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/Johnson_and_Johnson_corrosive_sublimate_cotton.jpg/220px-Johnson_and_Johnson_corrosive_sublimate_cotton.jpg" decoding="async" width="220" height="125" class="thumbimage" data-file-width="362" data-file-height="206"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 125px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/Johnson_and_Johnson_corrosive_sublimate_cotton.jpg/220px-Johnson_and_Johnson_corrosive_sublimate_cotton.jpg" data-alt="" data-width="220" data-height="125" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Johnson_and_Johnson_corrosive_sublimate_cotton.jpg" class="internal" title="Enlarge"></a></div>Early corrosive sublimate cotton packaging with the signature logo</div></div></div>
<p>Inspired by <a href="/wiki/Antiseptic" title="Antiseptic">antiseptic</a> advocate <a href="/wiki/Joseph_Lister,_1st_Baron_Lister" class="mw-redirect" title="Joseph Lister, 1st Baron Lister">Joseph Lister</a>, <a href="/wiki/Robert_Wood_Johnson_I" title="Robert Wood Johnson I">Robert Wood Johnson</a> joined his brothers, <a href="/wiki/James_Wood_Johnson" title="James Wood Johnson">James Wood Johnson</a> and <a href="/wiki/Edward_Mead_Johnson" title="Edward Mead Johnson">Edward Mead Johnson</a>, to create a line of ready-to-use <a href="/wiki/Dressing_(medical)" title="Dressing (medical)">surgical dressings</a> in 1885. The company produced its earliest products in 1886. Those products initially featured a logo that resembled the signature of James Wood Johnson, very similar to the logo used today.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10">[10]</a></sup><sup class="noprint Inline-Template noprint noexcerpt Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:NOTRS" class="mw-redirect" title="Wikipedia:NOTRS"><span title="This claim needs references to better sources. (February 2020)">better source needed</span></a></i>]</sup></p><p>Robert Wood Johnson served as the first president of the company. Upon his death in 1910, he was succeeded in the presidency by his brother James Wood Johnson until 1932, and then by his son, <a href="/wiki/Robert_Wood_Johnson_(son)" class="mw-redirect" title="Robert Wood Johnson (son)">Robert Wood Johnson II</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup></p><p>Robert Wood Johnson's granddaughter, <a href="/wiki/Mary_Lea_Johnson_Richards" title="Mary Lea Johnson Richards">Mary Lea Johnson Richards</a>, was the first baby to appear on a Johnson &amp; Johnson baby powder label.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">[11]</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">[12]</a></sup></p>
<div style="clear:both;"></div>
<h3 class="in-block"><span class="mw-headline" id="1943-44:_Credo_and_Going_Public">1943-44: Credo and Going Public</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=3" title="Edit section: 1943-44: Credo and Going Public" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 1943, as the company was preparing for its <a href="/wiki/Initial_public_offering" title="Initial public offering">initial public offering</a> (IPO), Robert Wood Johnson wrote what would become called by the company "Our Credo," a defining document that has been used to guide the company's decisions over the years.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">[13]</a></sup> The company completed its IPO and became a <a href="/wiki/Public_company" title="Public company">public company</a> in 1944.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">[14]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="1959:_McNeil_Consumer_Healthcare">1959: McNeil Consumer Healthcare</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=4" title="Edit section: 1959: McNeil Consumer Healthcare" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>McNeil Consumer Healthcare was founded on March 16, 1879, by Robert McNeil. In 1904, one of McNeil's sons, Robert Lincoln McNeil, became part of the company, and together they created McNeil Laboratories in 1933. The company focused on the <a href="/wiki/Direct_marketing" title="Direct marketing">direct marketing</a> of prescription drugs to hospitals, pharmacists, and doctors. The development of <a href="/wiki/Acetaminophen" class="mw-redirect" title="Acetaminophen">acetaminophen</a> began under the leadership of <a href="/wiki/Robert_L._McNeil,_Jr." class="mw-redirect" title="Robert L. McNeil, Jr.">Robert L. McNeil, Jr.</a>, who later served as the firm's chairman. In 1959, Johnson &amp; Johnson acquired McNeil Laboratories and a year later, the company was able to sell <a href="/wiki/Tylenol_(brand)" title="Tylenol (brand)">Tylenol</a> for the first time without a prescription.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">[15]</a></sup></p><p>In 1977, two subsidiary companies were created: McNeil Medicals Products and McNeil Consumer Products Company (also known as McNeil Consumer Healthcare). In 1993, McNeil Medicals Products merged with <a href="/wiki/Ortho_Pharmaceutical" title="Ortho Pharmaceutical">Ortho Pharmaceutical</a> to form <a href="/wiki/Ortho-McNeil_Pharmaceutical" title="Ortho-McNeil Pharmaceutical">Ortho-McNeil Pharmaceutical</a>. In 2001, McNeil Consumer Healthcare changed its name to McNeil Consumer &amp; Specialty Medicals Products. The name was later changed to "McNeil Consumer Healthcare".<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">[16]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="1959:_Cilag">1959: Cilag</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=5" title="Edit section: 1959: Cilag" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 1933, Swiss chemist <a href="/wiki/Bernhard_Joos" title="Bernhard Joos">Bernhard Joos</a>, set up a small research laboratory in <a href="/wiki/Schaffhausen" title="Schaffhausen">Schaffhausen</a>, Switzerland.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> This led to the founding of Chemische Industrie-Labor AG (Chemical Industry Laboratory AG or Cilag) on 12 May 1936.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> In 1959, Cilag joined Johnson &amp; Johnson.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> In the early 1990s, the marketing departments of Cilag and <a href="/wiki/Janssen_Pharmaceutica" title="Janssen Pharmaceutica">Janssen Pharmaceutica</a> joined to form Janssen-Cilag.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> The non-marketing departments still operate under their original name.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup></p>
<h3 class="in-block"><span class="mw-headline" id="1961:_Janssen_Pharmaceuticals">1961: Janssen Pharmaceuticals</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=6" title="Edit section: 1961: Janssen Pharmaceuticals" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 1933, <a href="/wiki/Constant_Janssen" title="Constant Janssen">Constant Janssen</a>, the father of Paul Janssen, acquired the right to distribute the pharmaceutical products of <a href="/wiki/Gedeon_Richter_Ltd." class="mw-redirect" title="Gedeon Richter Ltd.">Richter</a>, a Hungarian pharmaceutical company, for Belgium, the Netherlands and <a href="/wiki/Belgian_Congo" title="Belgian Congo">Belgian Congo</a>.<sup id="cite_ref-:1_17-0" class="reference"><a href="#cite_note-:1-17">[17]</a></sup> On 23 October 1934, he founded the N.V. Produkten Richter in <a href="/wiki/Turnhout" title="Turnhout">Turnhout</a>. After the Second World War, the name was changed to Eupharma, although the original company name Richter would remain until 1956.<sup id="cite_ref-:2_18-0" class="reference"><a href="#cite_note-:2-18">[18]</a></sup></p><p>In 1956, Paul Janssen founded his own research laboratory within the Richter-Eurpharma company of his father. On 5 April 1956, the name of the company was changed to NV Laboratoria Pharmaceutica C. Janssen (named after Constant Janssen).<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> On 2 May 1958, the research department in Beerse became a separate legal entity known as the N.V. Research Laboratorium C. Janssen. On 24 October 1961, the company was acquired by the American corporation Johnson &amp; Johnson.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">[19]</a></sup><sup id="cite_ref-:1_17-1" class="reference"><a href="#cite_note-:1-17">[17]</a></sup></p><p>On 10 February 1964, the name was changed to Janssen Pharmaceutica N.V.<sup id="cite_ref-:2_18-1" class="reference"><a href="#cite_note-:2-18">[18]</a></sup> In 1999, clinical research and non-clinical development became a global organization within Johnson &amp; Johnson.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> In 2001, a portion of their research activities were transferred to the United States and reorganized under the <a href="/wiki/Johnson_%26_Johnson_Pharmaceutical_Research_and_Development" title="Johnson &amp; Johnson Pharmaceutical Research and Development">Johnson &amp; Johnson Pharmaceutical Research and Development</a> organization.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> The research activities of the Janssen Research Foundation and the R.W. Johnson Pharmaceutical Research Institute were merged into the new global research organization.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup> On 27 October 2004, the Paul Janssen Research Center was founded.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2020)">citation needed</span></a></i>]</sup></p><p>In August 2013, the company acquired Aragon Pharmaceuticals, Inc.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup> In November 2014, the company acquired Alios BioPharma, Inc. for $1.75 billion. As a result of the purchase, Alios was incorporated into the infectious diseases therapeutic area of Janssen Pharmaceuticals.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">[21]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="1998:_DePuy">1998: DePuy</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=7" title="Edit section: 1998: DePuy" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p><a href="/wiki/DePuy" title="DePuy">DePuy</a> was acquired by J&amp;J in 1998, rolling it into the Johnson &amp; Johnson Medical Devices group.
</p><p>In September 2010, Johnson &amp; Johnson announced it had completed the acquisition of Micrus Endovascular, manufacturer of minimally invasive devices for hemorrhagic and ischemic strokes. Micrus will operate under Codman Neurovascular, a business unit of Codman &amp; Shurtleff, Inc.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">[22]</a></sup></p><p>On June 14, 2012, Johnson and Johnson completed the acquisition of <a href="/wiki/Synthes" title="Synthes">Synthes</a> for $19.7 billion,<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">[23]</a></sup> which was then integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson &amp; Johnson which includes: Codman &amp; Shurteff, Inc., DePuy Mitek, Inc., DePuy Orthopaedics, Inc. and DePuy Spine, Inc. In February 2015, DePuy announced it would acquire Olive Medical Corporation.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">[24]</a></sup> In May 2016, DePuy Orthopaedics, Inc. acquired Biomedical Enterprises, Inc., an industry leader in small bone fixation.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">[25]</a></sup> Later in December of the same year, DePuy Synthes announced it would acquire Pulsar Vascular Inc., adding Pulsar to its Codman division.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">[26]</a></sup></p><p>In January 2017, the company acquired Interventional Spine, Inc.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">[27]</a></sup> In April 2017, Irish subsidiary DePuy Ireland Unlimited Company announced it would acquire Neuravi, a company with a portfolio of products for hemorrhagic and ischemic strokes for an undisclosed sum, with Codman Neuro being behind the deal.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">[28]</a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29">[29]</a></sup> In June, DePuy Synthes Products, Inc. announced it would acquire Innovative Surgical Solutions, LLC (trading as Sentio, LLC) for an undisclosed sum, bolstering the company's technology for innovative nerve localisation in spinal surgery.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">[30]</a></sup></p>
<h3 class="in-block"><span id="1999:_Janssen_Biotech.2C_Inc."></span><span class="mw-headline" id="1999:_Janssen_Biotech,_Inc.">1999: Janssen Biotech, Inc.</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=8" title="Edit section: 1999: Janssen Biotech, Inc." data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Janssen Biotech, Inc., formerly known as Centocor Biotech, Inc., is a biotechnology company that was founded in <a href="/wiki/Philadelphia" title="Philadelphia">Philadelphia</a> in 1979. In 1982, Centocor transitioned into a publicly traded company. In 1999, Centocor became a wholly owned subsidiary of Johnson &amp; Johnson. Since the acquisition, Janssen Biotech increased its annual sales from $500 million to more than $2 billion. During the same period, research and development investment increased from $75 million to more than $300 million.
</p><p>In 2008, Centocor, Inc. and Ortho Biotech Inc. merged to form Centocor Ortho Biotech Inc. In June 2009 Johnson &amp; Johnson, through a new wholly owned subsidiary, Kite Merger Sub, Inc., announced it would purchase all outstanding shares of common stock of Cougar Biotechnology, Inc. for $43.00 in cash or around $970 million.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31">[31]</a></sup><sup id="cite_ref-32" class="reference"><a href="#cite_note-32">[32]</a></sup> In the same year, Johnson &amp; Johnson Nordic AB acquired Amic, developer of in vitro diagnostic, further strengthening the Ortho-Clinical Diagnostics division.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">[33]</a></sup></p><p>In June 2010, Centocor Ortho Biotech acquired RespiVert, a privately held <a href="/wiki/Drug_discovery" title="Drug discovery">drug discovery</a> company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">[34]</a></sup> In June 2011, Centocor Ortho Biotech changed its name to Janssen Biotech, Inc. as part of a global effort to unite the Janssen Pharmaceutical Companies around the world under a common identity. In December 2014, the company announced it would co-develop MacroGenics cancer drug candidate (MGD011) which targets both <a href="/wiki/CD19" title="CD19">CD19</a> and <a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a> proteins in treating <a href="/wiki/B-cell" class="mw-redirect" title="B-cell">B-cell</a> malignant tumours. This could net MacroGenics up to $700 million.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">[35]</a></sup> In January 2015, the company announced it will utilise <a href="/wiki/Isis_Pharmaceutical" class="mw-redirect" title="Isis Pharmaceutical">Isis Pharmaceuticals</a>' RNA-targeting technology to discover and develop <a href="/wiki/Antisense" class="mw-redirect" title="Antisense">antisense</a> drugs targeting autoimmune disorders of the <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract">gastrointestinal tract</a>, with the partnership potentially generating up to $835 million for Isis.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">[36]</a></sup> In May 2018, Janssen announced it would acquire BeneVir Biopharm, Inc. for an undisclosed sum.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">[37]</a></sup></p><p>In December 2019 XBiotech Inc. announced it would sell its novel antibody treatment (<a href="/wiki/Bermekimab" title="Bermekimab">bermekimab</a>) that neutralizes <a href="/wiki/Interleukin-1" class="mw-redirect" title="Interleukin-1">interleukin-1</a> alpha (IL-1⍺) to Janssen Biotech, Inc. for $750 million plus up to a further $600 million.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">[38]</a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39">[39]</a></sup></p>
<h3 class="in-block"><span id="Ethicon.2C_Inc."></span><span class="mw-headline" id="Ethicon,_Inc.">Ethicon, Inc.</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=9" title="Edit section: Ethicon, Inc." data-section="9" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 1915, <a href="/wiki/George_F._Merson" title="George F. Merson">George F. Merson</a> opened a facility in Edinburgh for the manufacturing, packaging and sterilizing of catgut, silk and nylon sutures. Johnson &amp; Johnson acquired Mr. Merson's company in 1947, and this was renamed Ethicon Suture Laboratories.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">[40]</a></sup> In 1953 this became Ethicon Inc.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">[41]</a></sup> In 1992, Ethicon was restructured, and <a href="/wiki/Ethicon_Endo-Surgery,_Inc." class="mw-redirect" title="Ethicon Endo-Surgery, Inc.">Ethicon Endo-Surgery, Inc.</a> became a separate corporation. During the 1990s, Ethicon diversified into new and advanced products and technologies and formed four different companies under the Ethicon umbrella, each of which specializes in different products.
</p><p>In 2008 J&amp;J announced it would acquire <a href="/wiki/Mentor_Corporation" class="mw-redirect" title="Mentor Corporation">Mentor Corporation</a> for $1 billion and merge its operations into Ethicon.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">[42]</a></sup> In the same year, Ethicon acquired Omrix Biopharmaceuticals, Inc. for $25 per share,<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">[43]</a></sup> or $438 million in total.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">[44]</a></sup> In May 2012 Johnson &amp; Johnson (China) Investment Ltd announced it would acquire surgery blood clotting developer, Guangzhou Bioseal Biotechnology Co., Ltd.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">[45]</a></sup> In March 2016, J&amp;Js Ethicon business unit announced it would acquire NeuWave Medical, Inc.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">[46]</a></sup> In January 2017, J&amp;J subsidiary Ethicon announced it would acquire Megadyne Medical Products, Inc., a medical device company that develops, manufactures and markets electrosurgical tools.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47">[47]</a></sup> In February 2017, Ethicon acquired medical device manufacturer, Torax Medical for an undisclosed sum.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">[48]</a></sup> In June 2018, the business announced that Advanced Sterilization Products would be sold off to <a href="/wiki/Fortive_Corporation" class="mw-redirect" title="Fortive Corporation">Fortive Corporation</a> for around $2.8 billion.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">[49]</a></sup></p><p>In February 2019, Johnson &amp; Johnson announced that Ethicon had agreed to acquire surgical robotic company, Auris Health Inc, for $3.4 billion in cash<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">[50]</a></sup> and over $2.3 billion in contingent payments based on performance.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">[51]</a></sup><sup id="cite_ref-52" class="reference"><a href="#cite_note-52">[52]</a></sup> In December of the same year, the company announced it would acquire the portion of Verb Surgical Inc, that it did not already own, from Verily, Alphabet's life sciences division.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">[53]</a></sup></p>
<h4 class="in-block"><span id="Ethicon_Endo-Surgery.2C_Inc."></span><span class="mw-headline" id="Ethicon_Endo-Surgery,_Inc.">Ethicon Endo-Surgery, Inc.</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=10" title="Edit section: Ethicon Endo-Surgery, Inc." data-section="10" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p><a href="/wiki/Ethicon_Endo-Surgery" class="mw-redirect" title="Ethicon Endo-Surgery">Ethicon Endo-Surgery</a> was part of Ethicon Inc. until 1992, when it became a separate corporate entity under the J&amp;J umbrella. In 2008 Ethicon Endo-Surgery acquired tissue sealing system developer, SurgRx, Inc.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">[54]</a></sup> In September 2011 the business acquired SterilMed, Inc.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">[55]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Actelion">Actelion</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=11" title="Edit section: Actelion" data-section="11" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In January 2017, J&amp;J fought off competition from <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a> to acquire Swiss drugmaker <a href="/wiki/Actelion" title="Actelion">Actelion</a>. Later in the month J&amp;J announced a $30 billion deal, the largest ever pursued by the company,<sup id="cite_ref-:0_56-0" class="reference"><a href="#cite_note-:0-56">[56]</a></sup> to purchase the Swiss company <a href="/wiki/Actelion" title="Actelion">Actelion</a> and to spin off its research and development unit, into a separate legal entity.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">[57]</a></sup><sup id="cite_ref-wsj-rockoff_58-0" class="reference"><a href="#cite_note-wsj-rockoff-58">[58]</a></sup> In March, the company declared its tender offer for Swiss biotechnology company Actelion successful on Friday, reporting that Janssen Holding GmbH controlled 77.2 percent of the voting rights after the main offer period,<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">[59]</a></sup> equating to 83,195,346 Actelion shares. In keeping with earlier agreements, the company announced its intention to delist Actelion, whilst spinning out its drug discovery operations and early-stage clinical development assets into a newly created Swiss-based biopharmaceutical company, Idorsia Ltd.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">[60]</a></sup> J&amp;J will control 16% of Idorsia, with the ability to raise their stake to 32% through convertible notes.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61">[61]</a></sup></p>
<h3 class="in-block"><span id="Johnson_.26_Johnson_Vision_Care.2C_Inc."></span><span class="mw-headline" id="Johnson_&amp;_Johnson_Vision_Care,_Inc.">Johnson &amp; Johnson Vision Care, Inc.</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=12" title="Edit section: Johnson &amp; Johnson Vision Care, Inc." data-section="12" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In July 2016, J&amp;J announced its intention to acquire the privately held company, Vogue International LLC, boosting Johnson &amp; Johnson Consumer Inc.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62">[62]</a></sup> In September of the same year, J&amp;J announced it would acquire <a href="/wiki/Abbott_Laboratories" title="Abbott Laboratories">Abbott Medical Optics</a> from <a href="/wiki/Abbott_Laboratories" title="Abbott Laboratories">Abbott Laboratories</a> for $4.325 billion, adding the new division into Johnson &amp; Johnson Vision Care, Inc.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">[63]</a></sup></p><p>In July 2017, Johnson &amp; Johnson Vision Care, Inc announced that its Abbott Medical Optics subsidiary would acquire <a href="/wiki/TearScience" title="TearScience">TearScience</a>, who recently received FDA approval for an office-based approach to imaging <a href="/wiki/Meibomian_glands" class="mw-redirect" title="Meibomian glands">meibomian glands</a> and treating <a href="/wiki/Meibomian_gland_dysfunction" class="mw-redirect" title="Meibomian gland dysfunction">meibomian gland dysfunction</a>.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64">[64]</a></sup> In September, the company acquired subscription-based contact lens startup Sightbox.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">[65]</a></sup></p><p>In 2019, Johnson &amp; Johnson announced the release of photochromic contact lenses. The lenses adjust to sunlight and help eyes recover from bright light exposure faster. The lenses contain a photochromic additive that adapts visible light amounts filtered to the eyes and are the first to use such additives.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">[66]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2010_onwards">2010 onwards</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=13" title="Edit section: 2010 onwards" data-section="13" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In October 2010, J&amp;J acquired <a href="/wiki/Crucell" title="Crucell">Crucell</a> for $2.4 billion<sup id="cite_ref-67" class="reference"><a href="#cite_note-67">[67]</a></sup> and will operate as the centre for vaccines, within the wider Johnson &amp; Johnson pharmaceuticals group.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68">[68]</a></sup></p><p>In November 2015, Biosense Webster, Inc. acquired Coherex, Medical Inc. expanding the companies range of treatment options for patients with <a href="/wiki/Atrial_fibrillation" title="Atrial fibrillation">atrial fibrillation</a>.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69">[69]</a></sup></p><p>In March 2018, the company announced that <a href="/wiki/LifeScan,_Inc." class="mw-redirect" title="LifeScan, Inc.">LifeScan, Inc.</a> would be sold off to <a href="/wiki/Platinum_Equity" title="Platinum Equity">Platinum Equity</a> for around $2.1 billion.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70">[70]</a></sup> In September of the same year Johnson &amp; Johnson Medical GmbH acquired Emerging Implant Technologies GmbH, manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71">[71]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Structure">Structure</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=14" title="Edit section: Structure" data-section="14" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<div class="mw-collapsible mw-collapsed" style="box-sizing:border-box;width:100%;font-size:95%;padding:4px;border:1px #aaa solid;"><div style="font-size:100%;line-height:1.6;font-weight:bold;background:transparent;text-align:center;;">Johnson &amp; Johnson Structure</div><div class="mw-collapsible-content" style="background:transparent;text-align:left;;">
<style data-mw-deduplicate="TemplateStyles:r886050385">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url("//upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class="treeview">
<ul><li><b>Johnson &amp; Johnson</b>
<ul><li>Johnson &amp; Johnson Consumer Inc. <small>(Consumer Healthcare Division)</small>
<ul><li>Baby Care</li>
<li>Skin &amp; Hair Care
<ul><li>Dabao Cosmetics Co.</li>
<li>Johnson &amp; Johnson Consumer France SAS
<ul><li>Groupe Vendome SA</li></ul></li></ul></li>
<li>Wound Care and Topicals</li>
<li>Oral Health Care</li>
<li>Women's Health</li>
<li>Over-The-Counter Medicines
<ul><li>Pfizer Consumer Healthcare <small>(Acq 2006)</small></li></ul></li>
<li>Wellness &amp; Prevention
<ul><li>LGE Performance Systems, Inc.</li>
<li>HealthMedia, Inc.</li></ul></li>
<li>Nutritionals</li>
<li>Vogue International LLC</li>
<li>TriStrata Inc.
<ul><li>NeoStrata Company, Inc.</li></ul></li>
<li>Zarbee's, Inc.</li></ul></li>
<li>Medical Devices Division
<ul><li><a href="/wiki/Biosense_Webster" class="mw-redirect" title="Biosense Webster">Biosense Webster</a>
<ul><li>Coherex Medical, Inc.</li></ul></li>
<li><a href="/wiki/DePuy" title="DePuy">DePuy</a> <a href="/wiki/Synthes" title="Synthes">Synthes</a>
<ul><li>Codman &amp; Shurteff, Inc.
<ul><li>Micrus Endovascular</li>
<li>Pulsar Vascular Inc.</li>
<li>Neuravi</li></ul></li>
<li>DePuy Mitek, Inc.</li>
<li>DePuy Orthopaedics, Inc.
<ul><li>Biomedical Enterprises, Inc.</li></ul></li>
<li>DePuy Spine, Inc
<ul><li>Interventional Spine, Inc.</li></ul></li>
<li>DePuy Synthes Products, Inc
<ul><li>Sentio, LLC</li></ul></li>
<li>Olive Medical Corporation</li>
<li>Advanced Sterilization Products (Divested 2018)
<ul><li>Apsis SAS
<ul><li>Gloster Europe</li>
<li>Orthotaxy</li></ul></li></ul></li>
<li>Johnson &amp; Johnson Medical GmbH
<ul><li>Surgical Process Institute</li>
<li>Emerging Implant Technologies GmbH</li></ul></li></ul></li>
<li><a href="/wiki/Ethicon,_Inc." class="mw-redirect" title="Ethicon, Inc.">Ethicon, Inc.</a>
<ul><li>Maple Merger Sub, Inc.
<ul><li>Mentor</li></ul></li>
<li>Binder Merger Sub, Inc.
<ul><li>Omrix Biopharmaceuticals, Inc.</li></ul></li>
<li>Acclarent</li>
<li>NeuWave Medical, Inc</li>
<li>Torax Medical</li>
<li>Johnson &amp; Johnson (China) Investment Ltd
<ul><li>Guangzhou Bioseal Biotechnology Co., Ltd.</li></ul></li>
<li><a href="/wiki/Ethicon_Endo-Surgery" class="mw-redirect" title="Ethicon Endo-Surgery">Ethicon Endo-Surgery</a>
<ul><li>SurgRx, Inc.</li>
<li>SterilMed, Inc.</li>
<li>Megadyne Medical Products, Inc.</li></ul></li>
<li>Auris Health Inc</li>
<li>Verb Surgical Inc</li></ul></li></ul></li>
<li>Janssen Diagnostics BVBA</li>
<li>Johnson &amp; Johnson Vision Care, Inc.
<ul><li><a href="/wiki/Vistakon" class="mw-redirect" title="Vistakon">Vistakon</a></li>
<li><a href="/wiki/Abbott_Medical_Optics" title="Abbott Medical Optics">Abbott Medical Optics</a>
<ul><li><a href="/wiki/TearScience" title="TearScience">TearScience</a></li></ul></li>
<li>Sightbox</li></ul></li>
<li>Pharmaceuticals Division
<ul><li><a href="/wiki/Janssen_Pharmaceutica" title="Janssen Pharmaceutica">Janssen Pharmaceutica</a>
<ul><li><a href="/wiki/Cilag" title="Cilag">Cilag</a>
<ul><li>J B Chemicals &amp; Pharmaceuticals Limited (OTC Division)</li>
<li>Covagen</li></ul></li>
<li><a href="/wiki/Janssen-Cilag" class="mw-redirect" title="Janssen-Cilag">Janssen-Cilag</a></li>
<li>CorImmun GmbH</li>
<li>Aragon Pharmaceuticals, Inc.</li>
<li>Alios BioPharma, Inc.</li>
<li>Novira Therapeutics, Inc.</li>
<li><a href="/wiki/Actelion" title="Actelion">Actelion</a></li></ul></li>
<li>Janssen R&amp;D LLC</li>
<li>Janssen Healthcare Innovation</li>
<li>Janssen Biotech, Inc.
<ul><li>Ortho Biotech Inc.
<ul><li>Ortho-Clinical Diagnostics, Inc.
<ul><li>Johnson &amp; Johnson Nordic AB
<ul><li>Amic AB</li></ul></li></ul></li></ul></li>
<li>Kite Merger Sub, Inc.
<ul><li>Cougar Biotechnology, Inc.</li></ul></li>
<li>RespiVert</li>
<li>BeneVir Biopharm, Inc.</li></ul></li>
<li><a href="/wiki/Janssen_Therapeutics" class="mw-redirect" title="Janssen Therapeutics">Janssen Therapeutics</a></li>
<li>Janssen Diagnostics</li>
<li>Janssen Scientific Affairs</li>
<li>JJC Acquisition Company B.V.
<ul><li><a href="/wiki/Crucell" title="Crucell">Crucell</a></li></ul></li>
<li>Ortho-McNeil-Janssen Pharmaceutical Services, Inc.
<ul><li>Janssen-Ortho</li>
<li>Ortho-McNeil</li>
<li><a href="/wiki/McNeil_Consumer_Healthcare" title="McNeil Consumer Healthcare">McNeil Consumer Healthcare</a></li></ul></li></ul></li></ul></li></ul></div>
</div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Finance">Finance</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=15" title="Edit section: Finance" data-section="15" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<p>For the fiscal year 2018, Johnson &amp; Johnson reported earnings of US$15.3 billion, with an annual revenue of US$81.6 billion, an increase of 6.7% over the previous fiscal cycle. Johnson &amp; Johnson's shares traded at over $126 per share, and its market capitalization was valued at over US$367.5 billion in September 2018.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">[72]</a></sup></p>
<table class="wikitable float-left" style="text-align: right;"><tbody><tr><th>Year
</th>
<th>Revenue<br>in mil. US$
</th>
<th>Net income<br>in mil. US$
</th>
<th>Employees<sup id="cite_ref-73" class="reference"><a href="#cite_note-73">[73]</a></sup></th></tr><tr><td>2005
</td>
<td>50,514
</td>
<td>10,060
</td>
<td>115,600
</td></tr><tr><td>2006
</td>
<td>53,324
</td>
<td>11,053
</td>
<td>122,200
</td></tr><tr><td>2007
</td>
<td>61,095
</td>
<td>10,576
</td>
<td>119,200
</td></tr><tr><td>2008
</td>
<td>63,747
</td>
<td>12,949
</td>
<td>118,700
</td></tr><tr><td>2009
</td>
<td>61,897
</td>
<td>12,266
</td>
<td>115,500
</td></tr><tr><td>2010
</td>
<td>61,587
</td>
<td>13,334
</td>
<td>114,000
</td></tr><tr><td>2011
</td>
<td>65,030
</td>
<td>9,672
</td>
<td>117,900
</td></tr><tr><td>2012
</td>
<td>67,224
</td>
<td>10,853
</td>
<td>127,600
</td></tr><tr><td>2013
</td>
<td>71,312
</td>
<td>13,831
</td>
<td>128,100
</td></tr><tr><td>2014
</td>
<td>74,331
</td>
<td>16,323
</td>
<td>126,500
</td></tr><tr><td>2015
</td>
<td>70,074
</td>
<td>15,409
</td>
<td>127,100
</td></tr><tr><td>2016
</td>
<td>71,890
</td>
<td>16,540
</td>
<td>126,400
</td></tr><tr><td>2017
</td>
<td>76,450
</td>
<td>1,300
</td>
<td>155,000
</td></tr><tr><td>2018
</td>
<td>81,581
</td>
<td>15,297
</td>
<td>134,000
</td></tr><tr><td>2019
</td>
<td>82,059
</td>
<td>15,119
</td>
<td>132,200
</td></tr></tbody></table></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Corporate_governance">Corporate governance</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=16" title="Edit section: Corporate governance" data-section="16" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<p>Current members of the board of directors of Johnson &amp; Johnson for 2019 are: Alex Gorsky, Mary C. Beckerle, D. Scott Davis, Ian E. L. Davis, Jennifer A. Doudna, Mark B. McClellan, Anne M. Mulcahy, William D. Perez, Charles Prince, A. Eugene Washington, Marillyn A. Hewson and Ronald A. Williams.<sup id="cite_ref-Johnson_&amp;_Johnson_Board_of_Directors_74-0" class="reference"><a href="#cite_note-Johnson_&amp;_Johnson_Board_of_Directors-74">[74]</a></sup></p><p>Current members of Executive Committees of Johnson &amp; Johnson are: Joseph Wolk (the company's <a href="/wiki/Chief_financial_officer" title="Chief financial officer">chief financial officer</a>),<sup id="cite_ref-:0_56-1" class="reference"><a href="#cite_note-:0-56">[56]</a></sup> Peter Fasolo, <a href="/wiki/Paul_Stoffels" title="Paul Stoffels">Paul Stoffels</a>, and Michael Sneed.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75">[75]</a></sup></p><p>On July 2, 2018, Johnson &amp; Johnson's head of pharmaceuticals, Joaquin Duato, became the vice chairman of the executive committee.<sup id="cite_ref-76" class="reference"><a href="#cite_note-76">[76]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Chairmen">Chairmen</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=17" title="Edit section: Chairmen" data-section="17" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<ul><li><a href="/wiki/Robert_Wood_Johnson_I" title="Robert Wood Johnson I">Robert Wood Johnson I</a> (1887–1910)</li>
<li><a href="/wiki/James_Wood_Johnson" title="James Wood Johnson">James Wood Johnson</a> (1910–1932)</li>
<li><a href="/wiki/Robert_Wood_Johnson_II" title="Robert Wood Johnson II">Robert Wood Johnson II</a> (1932–1963)</li>
<li><a href="/wiki/Philip_B._Hofmann" title="Philip B. Hofmann">Philip B. Hofmann</a> (1963–1973)</li>
<li><a href="/wiki/Richard_B._Sellars" title="Richard B. Sellars">Richard B. Sellars</a> (1973–1976)</li>
<li><a href="/wiki/James_E._Burke" title="James E. Burke">James E. Burke</a> (1976–1989)</li>
<li><a href="/wiki/Ralph_S._Larsen" title="Ralph S. Larsen">Ralph S. Larsen</a> (1989–2002)</li>
<li><a href="/wiki/William_C._Weldon" title="William C. Weldon">William C. Weldon</a> (2002–2012)</li>
<li><a href="/wiki/Alex_Gorsky" title="Alex Gorsky">Alex Gorsky</a> (2012–present)</li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Headquarters_and_the_New_Brunswick_gentrification">Headquarters and the New Brunswick gentrification</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=18" title="Edit section: Headquarters and the New Brunswick gentrification" data-section="18" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<p>The company has historically been located on the <a href="/wiki/Delaware_and_Raritan_Canal" title="Delaware and Raritan Canal">Delaware and Raritan Canal</a> in New Brunswick. The company considered moving its headquarters out of New Brunswick in the 1960s, but decided to stay in the town after city officials promised to revitalize downtown New Brunswick by demolishing old buildings and constructing new ones. While New Brunswick lost many historic structures, including the early home of Rutgers University, and most of its historic commercial waterfront to the redevelopment effort, the gentrification did attract people back to New Brunswick. Johnson &amp; Johnson hired <a href="/wiki/Henry_N._Cobb" title="Henry N. Cobb">Henry N. Cobb</a> from <a href="/wiki/Pei_Cobb_Freed_%26_Partners" title="Pei Cobb Freed &amp; Partners">Pei Cobb Freed &amp; Partners</a> to design its new headquarters. <a href="/wiki/Johnson_and_Johnson_Plaza" title="Johnson and Johnson Plaza">Johnson and Johnson Plaza</a>, in a park across the <a href="/wiki/Northeast_Corridor" title="Northeast Corridor">railroad tracks</a> from the older portion of the headquarters, is one of <a href="/wiki/List_of_tallest_buildings_in_New_Brunswick" class="mw-redirect" title="List of tallest buildings in New Brunswick">tallest buildings in New Brunswick</a>.
</p><p>The stretch of Delaware and Raritan canal by the company's headquarters was replaced by a stretch of <a href="/wiki/New_Jersey_Route_18" title="New Jersey Route 18">Route 18</a> in the late 1970s,<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">[77]</a></sup> after a lengthy dispute.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">[78]</a></sup> In 2002, the company released its plan of setting up <a href="/wiki/Asia-Pacific" title="Asia-Pacific">Asia-Pacific</a> information technology headquarters in New South Wales within five years.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79">[79]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Products">Products</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=19" title="Edit section: Products" data-section="19" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<p>The company's business is divided into three major segments, Pharmaceuticals, Medical Devices, and Consumer Products. In 2015, these segments contributed 44.9%, 35.9%, and 19.2%, respectively, of the company's total revenues.<sup id="cite_ref-80" class="reference"><a href="#cite_note-80">[80]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Pharmaceuticals">Pharmaceuticals</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=20" title="Edit section: Pharmaceuticals" data-section="20" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>The company's major franchises in the Pharmaceutical segment include Immunology, Neuroscience, Infectious Disease, and Oncology.
</p><p>Immunology products include the anti-<a href="/wiki/Tumor_necrosis_factor" class="mw-redirect" title="Tumor necrosis factor">tumor necrosis factor</a> antibodies Remicade (<a href="/wiki/Infliximab" title="Infliximab">infliximab</a>), and Simponi (<a href="/wiki/Golimumab" title="Golimumab">golimumab</a>) used for the treatment<sup id="cite_ref-81" class="reference"><a href="#cite_note-81">[81]</a></sup> of autoimmune diseases, including <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a> (Remicade only), <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a>, <a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">ankylosing spondylitis</a>, and other disorders. In 2013, these two products accounted for 29% of Johnson and Johnson's pharmaceutical revenues, and 11.3% of the company's total revenues. A third immunology product, Stelara (<a href="/wiki/Ustekinumab" title="Ustekinumab">ustekinumab</a>), targets <a href="/wiki/Interleukin-12" class="mw-redirect" title="Interleukin-12">interleukin-12</a> and <a href="/wiki/Interleukin-23" class="mw-redirect" title="Interleukin-23">interleukin-23</a> and is used for the treatment of <a href="/wiki/Psoriasis" title="Psoriasis">psoriasis</a>.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82">[82]</a></sup></p><p>The company's CNS products include the ADHD drug Concerta (<a href="/wiki/Methylphenidate" title="Methylphenidate">methylphenidate</a> extended release), and the long-acting injectable antipsychotics Invega Sustenna (<a href="/wiki/Paliperidone_palmitate" class="mw-redirect" title="Paliperidone palmitate">paliperidone palmitate</a>) and Risperdal Consta (<a href="/wiki/Risperidone" title="Risperidone">risperidone</a>). Invega Sustenna and Risperdal Consta were the first widely utilized long-acting depot injections for the treatment of schizophrenia. Designed to address the issue of poor patient compliance with oral therapy, they are administered by intramuscular injection at intervals of 2 weeks and one month, respectively. Only minimal improvements in outcomes relative to the oral versions of these drugs were observed in the clinical trial setting, but some evidence suggests that the advantages of long-acting injections in clinical practice may be greater than is readily demonstrated in the environment of a clinical trial.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83">[83]</a></sup><sup id="cite_ref-84" class="reference"><a href="#cite_note-84">[84]</a></sup><sup id="cite_ref-85" class="reference"><a href="#cite_note-85">[85]</a></sup></p><p>Oncology products include Velcade (<a href="/wiki/Bortezomib" title="Bortezomib">bortezomib</a>), for the treatment of multiple myeloma and mantle cell lymphoma<sup id="cite_ref-86" class="reference"><a href="#cite_note-86">[86]</a></sup> and Zytiga (<a href="/wiki/Abiraterone" title="Abiraterone">abiraterone</a>), an androgen antagonist for the treatment of prostate cancer. In clinical trials, abiraterone treatment was associated with a 4.6 to 5.2 survival advantage when used either before or after chemotherapy with platinum-based drugs.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87">[87]</a></sup> On December 31, 2012, the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> approved <a href="/wiki/Bedaquiline" title="Bedaquiline">Sirturo</a> (bedaquiline), a Johnson &amp; Johnson <a href="/wiki/Tuberculosis" title="Tuberculosis">tuberculosis</a> drug that is the first new medicine to fight the infection in more than forty years.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88">[88]</a></sup></p><p>Historically notable drugs include Incivio (<a href="/wiki/Telaprevir" title="Telaprevir">telaprevir</a>) for treating <a href="/wiki/Hepatitis_C" title="Hepatitis C">hepatitis C</a>, whose sales declined from $2.4 billion in 2014 to $106 million in 2016 as competing curative drugs emerged.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89">[89]</a></sup> HIV drugs include Edurant (<a href="/wiki/Rilpivirine" title="Rilpivirine">rilpivirine</a>), Intelence (<a href="/wiki/Etravirine" title="Etravirine">etravirine</a>) and Prezista (<a href="/wiki/Darunavir" title="Darunavir">darunavir</a>) but as of 2018, the most significant of these only accounted for around 2% of total revenue at $211 million.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">[90]</a></sup></p><p>In March 2019 the FDA approved <a href="/wiki/Esketamine" title="Esketamine">esketamine</a> for the treatment of severe depression,<sup id="cite_ref-91" class="reference"><a href="#cite_note-91">[91]</a></sup> which is marketed as Spravato by Janssen Pharmaceuticals.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92">[92]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Medical_devices">Medical devices</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=21" title="Edit section: Medical devices" data-section="21" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Sectors in which the company is active<sup id="cite_ref-93" class="reference"><a href="#cite_note-93">[93]</a></sup> include:
</p>
<div class="div-col columns column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;">
<ul><li>Aesthetics (Ethicon, Mentor)</li>
<li>Arrhythmias (Biosense Webster)</li>
<li>Bariatric Surgery for Obesity (Ethicon)</li>
<li>Cardiovascular Disease (Biosense Webster, Inc.)</li>
<li>Diabetes Care (LifeScan, Animas Corporation)</li>
<li>Ear, Nose, and Throat Conditions (Acclarent)</li>
<li>General Surgery (Ethicon, Codman Neuro)</li>
<li>Hernia Surgery (Ethicon)</li>
<li>Insulin Delivery Devices (Animas)</li>
<li>Neurovascular Disease (Codman Neuro, DePuy Synthes)</li>
<li>Orthopaedics (DePuy Synthes): Joint Reconstruction, Trauma, Spine, Sports Medicine and Power Tools</li>
<li>Self-Measured Blood Glucose Monitors (LifeScan)</li>
<li>Surgical Instruments and Infection Prevention(Advanced Sterilization Products)</li>
<li>Urologic Surgery (Ethicon)</li>
<li>Vision Care (VISTAKON®)</li></ul></div>
<h3 class="in-block"><span class="mw-headline" id="Consumer_health">Consumer health</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=22" title="Edit section: Consumer health" data-section="22" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Sectors in which the company is active<sup id="cite_ref-94" class="reference"><a href="#cite_note-94">[94]</a></sup> include:
</p>
<div class="div-col columns column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;">
<ul><li>Baby Care</li>
<li>Nutritionals</li>
<li>Oral Health Care</li>
<li>Over-the-Counter Medicines</li>
<li>Skin &amp; Hair Care</li>
<li>Vision Care</li>
<li>Wound Care &amp; Topicals</li></ul></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Environmental_record">Environmental record</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=23" title="Edit section: Environmental record" data-section="23" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<p>Johnson &amp; Johnson has set several positive goals to keep the company environmentally friendly and was ranked third among the United States's largest companies in <i><a href="/wiki/Newsweek" title="Newsweek">Newsweek</a>'s</i> "Green Rankings".<sup id="cite_ref-95" class="reference"><a href="#cite_note-95">[95]</a></sup> Some examples are the reduction in water use, waste, and energy use and an increased level of transparency.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96">[96]</a></sup> Johnson &amp; Johnson agreed to change its packaging of plastic bottles used in the manufacturing process, switching their packaging of liquids to non-<a href="/wiki/Polyvinyl_chloride" title="Polyvinyl chloride">polyvinyl chloride</a> containers.<sup id="cite_ref-ens_97-0" class="reference"><a href="#cite_note-ens-97">[97]</a></sup> The corporation is working with the Climate Northwest Initiative and the EPA National Environmental Performance Track program.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98">[98]</a></sup> As a member of the national Green Power Partnership, Johnson &amp; Johnson operates the largest solar power generator in Pennsylvania at its site in <a href="/wiki/Spring_House,_Pennsylvania" title="Spring House, Pennsylvania">Spring House, Pennsylvania</a>.<sup id="cite_ref-99" class="reference"><a href="#cite_note-99">[99]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Recalls_and_litigation">Recalls and litigation</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=24" title="Edit section: Recalls and litigation" data-section="24" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<h3 class="in-block"><span class="mw-headline" id="1982_Chicago_Tylenol_murders">1982 Chicago Tylenol murders</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=25" title="Edit section: 1982 Chicago Tylenol murders" data-section="25" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Chicago_Tylenol_murders" title="Chicago Tylenol murders">Chicago Tylenol murders</a></div>
<p>On September 29, 1982, a "Tylenol scare" began when the first of seven individuals died in <a href="/wiki/Chicago_metropolitan_area" title="Chicago metropolitan area">Chicago metropolitan area</a>, after ingesting Extra Strength Tylenol that had been deliberately laced with <a href="/wiki/Cyanide" title="Cyanide">cyanide</a>.<sup id="cite_ref-nytrecall_100-0" class="reference"><a href="#cite_note-nytrecall-100">[100]</a></sup> Within a week, the company pulled 31 million bottles of capsules back from retailers, making it one of the first major recalls in American history.<sup id="cite_ref-nytrecall_100-1" class="reference"><a href="#cite_note-nytrecall-100">[100]</a></sup> The incident led to reforms in the packaging of <a href="/wiki/Over-the-counter_substance" class="mw-redirect" title="Over-the-counter substance">over-the-counter substances</a> and to federal anti-tampering laws. The case remains unsolved and no suspects have been charged. Johnson &amp; Johnson's quick response, including a nationwide recall, was widely praised by <a href="/wiki/Public_relations" title="Public relations">public relations</a> experts and the media and was the gold standard for corporate crisis management.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101">[101]</a></sup><sup id="cite_ref-102" class="reference"><a href="#cite_note-102">[102]</a></sup><sup id="cite_ref-103" class="reference"><a href="#cite_note-103">[103]</a></sup></p>
<h3 class="in-block"><span id="2010_children.27s_product_recall"></span><span class="mw-headline" id="2010_children's_product_recall">2010 children's product recall</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=26" title="Edit section: 2010 children's product recall" data-section="26" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/2010_Johnson_%26_Johnson_children%27s_product_recall" title="2010 Johnson &amp; Johnson children's product recall">2010 Johnson &amp; Johnson children's product recall</a></div>
<p>On April 30, 2010, <a href="/wiki/McNeil_Consumer_Healthcare" title="McNeil Consumer Healthcare">McNeil Consumer Healthcare</a>, a subsidiary of Johnson and Johnson, voluntarily <a href="/wiki/Product_recall" title="Product recall">recalled</a> 43 <a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter</a> children's medicines, including <a href="/wiki/Tylenol_(brand_redirect)" class="mw-redirect" title="Tylenol (brand redirect)">Tylenol</a>, Tylenol Plus, <a href="/wiki/Motrin" class="mw-redirect" title="Motrin">Motrin</a>, <a href="/wiki/Zyrtec" class="mw-redirect" title="Zyrtec">Zyrtec</a> and <a href="/wiki/Benadryl" title="Benadryl">Benadryl</a>. The recall was conducted after a routine inspection at a manufacturing facility in <a href="/wiki/Fort_Washington,_Pennsylvania" title="Fort Washington, Pennsylvania">Fort Washington, Pennsylvania</a>, United States revealed that some "products may not fully meet the required manufacturing specifications".<sup id="cite_ref-US_firm_recalls_children's_drugs_104-0" class="reference"><a href="#cite_note-US_firm_recalls_children's_drugs-104">[104]</a></sup><sup id="cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-0" class="reference"><a href="#cite_note-Warning_As_Baby_Medicines_Are_Recalled-105">[105]</a></sup> Affected products may contain a "higher concentration of active ingredients" or exhibit other manufacturing defects.<sup id="cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-1" class="reference"><a href="#cite_note-Warning_As_Baby_Medicines_Are_Recalled-105">[105]</a></sup> Products shipped to Canada, Dominican Republic, <a href="/wiki/Guam" title="Guam">Guam</a>, Guatemala, Jamaica, <a href="/wiki/Puerto_Rico" title="Puerto Rico">Puerto Rico</a>, Panama, Trinidad and Tobago, the United Arab Emirates, Kuwait and Fiji were included in the recall.<sup id="cite_ref-US_firm_recalls_children's_drugs_104-1" class="reference"><a href="#cite_note-US_firm_recalls_children's_drugs-104">[104]</a></sup> In a statement, Johnson &amp; Johnson said "a comprehensive quality assessment across its manufacturing operations" was underway.<sup id="cite_ref-US_firm_recalls_children's_drugs_104-2" class="reference"><a href="#cite_note-US_firm_recalls_children's_drugs-104">[104]</a></sup><sup id="cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-2" class="reference"><a href="#cite_note-Warning_As_Baby_Medicines_Are_Recalled-105">[105]</a></sup> A dedicated website was established by the company <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100504052605/http://www.mcneilproductrecall.com/page.jhtml?id=%2Finclude%2Fnew_recall.inc">listing</a> affected products and other consumer information.<sup id="cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-3" class="reference"><a href="#cite_note-Warning_As_Baby_Medicines_Are_Recalled-105">[105]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2010_hip-replacement_recall">2010 hip-replacement recall</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=27" title="Edit section: 2010 hip-replacement recall" data-section="27" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/2010_DePuy_Hip_Recall" title="2010 DePuy Hip Recall">2010 DePuy Hip Recall</a></div>
<p>On August 24, 2010, DePuy, a subsidiary of American giant Johnson &amp; Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market. DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%. All hip prostheses fail in some patients, but it is expected that the rate will be about 1% a year.<sup id="cite_ref-Out_of_joint_106-0" class="reference"><a href="#cite_note-Out_of_joint-106">[106]</a></sup>
Pathologically, the failing prosthesis had several effects. Metal debris from wear of the implant led to a reaction that destroyed the soft tissues surrounding the joint, leaving some patients with long term disability. Ions of cobalt and chromium—the metals from which the implant was made—were also released into the blood and cerebral spinal fluid in some patients.<sup id="cite_ref-fda1_107-0" class="reference"><a href="#cite_note-fda1-107">[107]</a></sup></p><p>In March 2013, a jury in Los Angeles ordered Johnson &amp; Johnson to pay more than $8.3 million in damages to a Montana man in the first of more than 10,000 lawsuits pending against the company in connection with the now-recalled DePuy hip.<sup id="cite_ref-Meier_108-0" class="reference"><a href="#cite_note-Meier-108">[108]</a></sup></p><p>Some lawyers and industry analysts have estimated that the suits ultimately will cost Johnson &amp; Johnson billions of dollars to resolve.<sup id="cite_ref-Meier_108-1" class="reference"><a href="#cite_note-Meier-108">[108]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2010_Tylenol_recall">2010 Tylenol recall</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=28" title="Edit section: 2010 Tylenol recall" data-section="28" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2010 and 2011, Johnson &amp; Johnson voluntarily recalled some <a href="/wiki/Over-the-counter" class="mw-redirect" title="Over-the-counter">over-the-counter</a> products, including Tylenol, due to an odor caused by tribromoanisole.<sup id="cite_ref-WebMd_109-0" class="reference"><a href="#cite_note-WebMd-109">[109]</a></sup><sup id="cite_ref-110" class="reference"><a href="#cite_note-110">[110]</a></sup> In this case, <a href="/wiki/2,4,6-tribromophenol" class="mw-redirect" title="2,4,6-tribromophenol">2,4,6-tribromophenol</a> was used to treat wooden pallets on which product packaging materials were transported and stored.<sup id="cite_ref-WebMd_109-1" class="reference"><a href="#cite_note-WebMd-109">[109]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Shareholders_lawsuit">Shareholders lawsuit</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=29" title="Edit section: Shareholders lawsuit" data-section="29" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2010 a group of <a href="/wiki/Shareholders" class="mw-redirect" title="Shareholders">shareholders</a> sued the board for allegedly failing to take action to prevent serious failings and illegalities since the 1990s, including manufacturing problems, bribing officials, covering up adverse effects and misleading marketing for unapproved uses. The judge initially dismissed the case in September 2011, but allowed the plaintiffs opportunity to refile at a later time.<sup id="cite_ref-111" class="reference"><a href="#cite_note-111">[111]</a></sup> In 2012 Johnson and Johnson proposed a settlement with the shareholders, whereby the company would institute new oversight, quality and compliance procedures binding for five years.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">[112]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Illegal_marketing_of_Risperdal">Illegal marketing of Risperdal</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=30" title="Edit section: Illegal marketing of Risperdal" data-section="30" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Juries in several US states have found J&amp;J guilty of concealing the <a href="/wiki/Adverse_effects" class="mw-redirect" title="Adverse effects">adverse effects</a> of <a href="/wiki/Janssen_Pharmaceuticals" class="mw-redirect" title="Janssen Pharmaceuticals">Janssen Pharmaceuticals</a>' <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> medication <a href="/wiki/Risperdal" class="mw-redirect" title="Risperdal">Risperdal</a>, produced by its unit, in order to promote it to doctors and patients as better than cheaper generics, and of falsely marketing it for treating patients with <a href="/wiki/Dementia" title="Dementia">dementia</a>.<sup id="cite_ref-CNNMoney_113-0" class="reference"><a href="#cite_note-CNNMoney-113">[113]</a></sup> States that have awarded damages include <a href="/wiki/Texas" title="Texas">Texas</a> ($158 million), <a href="/wiki/South_Carolina" title="South Carolina">South Carolina</a> ($327 million), <a href="/wiki/Louisiana" title="Louisiana">Louisiana</a> ($258 million), and most notably <a href="/wiki/Arkansas" title="Arkansas">Arkansas</a> ($1.2 billion).<sup id="cite_ref-114" class="reference"><a href="#cite_note-114">[114]</a></sup></p><p>In 2010, the <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">United States Department of Justice</a> joined a <a href="/wiki/Whistleblowers" class="mw-redirect" title="Whistleblowers">whistleblowers</a> suit accusing the company of illegally marketing Risperdal through <a href="/wiki/Omnicare" title="Omnicare">Omnicare</a>, the largest company supplying pharmaceuticals to nursing homes.<sup id="cite_ref-Hilzenrath_115-0" class="reference"><a href="#cite_note-Hilzenrath-115">[115]</a></sup><sup id="cite_ref-116" class="reference"><a href="#cite_note-116">[116]</a></sup> The allegations include that J&amp;J were warned by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) not to promote Risperdal as effective and safe for elderly patients, but they did so, and that they paid Omnicare to promote the drug to care home physicians.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117">[117]</a></sup> The settlement was finalized on November 4, 2013, with J&amp;J agreeing to pay a penalty of around $2.2 billion, "including criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion".<sup id="cite_ref-DOH2013_118-0" class="reference"><a href="#cite_note-DOH2013-118">[118]</a></sup></p><p>Johnson &amp; Johnson has also been subject to congressional investigations related to payments given to <a href="/wiki/Psychiatrists" class="mw-redirect" title="Psychiatrists">psychiatrists</a> to promote its products and <a href="/wiki/Ghost_writer" class="mw-redirect" title="Ghost writer">ghost write</a> articles, notably <a href="/wiki/Joseph_Biederman" title="Joseph Biederman">Joseph Biederman</a> and his pediatric <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a> research unit.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119">[119]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Foreign_bribery">Foreign bribery</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=31" title="Edit section: Foreign bribery" data-section="31" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2011, J&amp;J settled litigation brought by the <a href="/wiki/US_Securities_and_Exchange_Commission" class="mw-redirect" title="US Securities and Exchange Commission">US Securities and Exchange Commission</a> under the <a href="/wiki/Foreign_Corrupt_Practices_Act" title="Foreign Corrupt Practices Act">Foreign Corrupt Practices Act</a> and paid around $70M in disgorgement and fines.<sup id="cite_ref-120" class="reference"><a href="#cite_note-120">[120]</a></sup> J&amp;J's employees had given kickbacks and bribes to doctors in Greece, Poland, and Romania to obtain business selling drugs and medical devices and had bribed officials in <a href="/wiki/Iraq" title="Iraq">Iraq</a> to win contracts under the Oil for Food program.<sup id="cite_ref-121" class="reference"><a href="#cite_note-121">[121]</a></sup> J&amp;J fully cooperated with the investigation once the problems came to light.<sup id="cite_ref-FCPA2011_122-0" class="reference"><a href="#cite_note-FCPA2011-122">[122]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Consumer_fraud_settlements">Consumer fraud settlements</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=32" title="Edit section: Consumer fraud settlements" data-section="32" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In May 2017, J&amp;J reached an agreement to pay $33 million to several states to settle consumer fraud allegations in some of the company's over-the-counter drugs.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123">[123]</a></sup><sup id="cite_ref-124" class="reference"><a href="#cite_note-124">[124]</a></sup><sup id="cite_ref-125" class="reference"><a href="#cite_note-125">[125]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Use_of_the_Red_Cross_symbol">Use of the Red Cross symbol</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=33" title="Edit section: Use of the Red Cross symbol" data-section="33" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Emblems_of_the_International_Red_Cross_and_Red_Crescent_Movement#Use_of_the_emblems" title="Emblems of the International Red Cross and Red Crescent Movement">Emblems of the International Red Cross and Red Crescent Movement § Use of the emblems</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:152px;"><a href="/wiki/File:Flag_of_the_Red_Cross.svg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Flag_of_the_Red_Cross.svg/150px-Flag_of_the_Red_Cross.svg.png" decoding="async" width="150" height="100" class="thumbimage" data-file-width="900" data-file-height="600"></noscript><span class="lazy-image-placeholder" style="width: 150px;height: 100px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Flag_of_the_Red_Cross.svg/150px-Flag_of_the_Red_Cross.svg.png" data-alt="" data-width="150" data-height="100" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Flag_of_the_Red_Cross.svg/225px-Flag_of_the_Red_Cross.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Flag_of_the_Red_Cross.svg/300px-Flag_of_the_Red_Cross.svg.png 2x" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Flag_of_the_Red_Cross.svg" class="internal" title="Enlarge"></a></div>Flag of the <a href="/wiki/Red_Cross" class="mw-redirect" title="Red Cross">Red Cross</a></div></div></div>
<p>Johnson &amp; Johnson registered the <a href="/wiki/Red_Cross" class="mw-redirect" title="Red Cross">Red Cross</a> as a U.S. trademark for "medicinal and surgical plasters" in 1905 and has used the design since 1887.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126">[126]</a></sup> The <a href="/wiki/Geneva_Conventions" title="Geneva Conventions">Geneva Conventions</a>, which reserved the <a href="/wiki/Emblems_of_the_International_Red_Cross_and_Red_Crescent_Movement#Red_Cross" title="Emblems of the International Red Cross and Red Crescent Movement">Red Cross emblem</a> for specific uses, were first approved in 1864 and ratified by the United States in 1882. However, the emblem was not protected by U.S. law for the use of the <a href="/wiki/American_Red_Cross" title="American Red Cross">American Red Cross</a> and the U.S. military until after Johnson &amp; Johnson had obtained its trademark. A clause in this law (now 18 U.S.C. 706) permits this pre-existing use of the Red Cross to continue.
</p><p>A declaration made by the U.S. upon its ratification of the 1949 Geneva Conventions includes a <a href="/wiki/Reservation_(law)" title="Reservation (law)">reservation</a> that pre-1905 U.S. domestic uses of the Red Cross, such as Johnson &amp; Johnson's, would remain lawful as long as the cross is not used on "aircraft, vessels, vehicles, buildings or other structures, or upon the ground," i.e., uses which could be confused with its military uses.<sup id="cite_ref-127" class="reference"><a href="#cite_note-127">[127]</a></sup> This means that the U.S. did not agree to any interpretation of the 1949 Geneva Conventions that would overrule Johnson &amp; Johnson's trademark. The American Red Cross continues to recognize the validity of Johnson &amp; Johnson's trademark.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128">[128]</a></sup></p><p>In August 2007, Johnson &amp; Johnson filed a lawsuit against the <a href="/wiki/American_Red_Cross" title="American Red Cross">American Red Cross</a> (ARC), demanding that the charity halt the use of the red cross symbol on products it sells to the public, though the company takes no issue with the charity's use of the mark for non-profit purposes.<sup id="cite_ref-129" class="reference"><a href="#cite_note-129">[129]</a></sup> In May 2008, the judge in the case dismissed most of Johnson &amp; Johnson's claims, and a month later the two organizations announced a settlement had been reached in which both parties would continue to use the symbol.<sup id="cite_ref-130" class="reference"><a href="#cite_note-130">[130]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Boston_Scientific_lawsuits">Boston Scientific lawsuits</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=34" title="Edit section: Boston Scientific lawsuits" data-section="34" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Since 2003, Johnson &amp; Johnson and <a href="/wiki/Boston_Scientific" title="Boston Scientific">Boston Scientific</a> have both claimed that the other had infringed on their patents covering <a href="/wiki/Heart_stent" class="mw-redirect" title="Heart stent">heart stent</a> medical devices. The litigation was settled when Boston Scientific agreed to pay $716 million to Johnson &amp; Johnson in September 2009 and an additional $1.73 billion in February 2010.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131">[131]</a></sup> Their dispute was renewed in 2014, now on the grounds of a contract dispute.<sup id="cite_ref-132" class="reference"><a href="#cite_note-132">[132]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Patent-infringement_case_against_Abbott">Patent-infringement case against Abbott</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=35" title="Edit section: Patent-infringement case against Abbott" data-section="35" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In 2007, Johnson &amp; Johnson sued <a href="/wiki/Abbott_Laboratories" title="Abbott Laboratories">Abbott Laboratories</a> over the development and sale of the arthritis drug <a href="/wiki/Humira" class="mw-redirect" title="Humira">Humira</a>. Johnson &amp; Johnson claimed that Abbott used technology patented by <a href="/wiki/New_York_University" title="New York University">New York University</a> and licensed exclusively to Johnson &amp; Johnson's <a href="/wiki/Centocor" class="mw-redirect" title="Centocor">Centocor</a> division to develop Humira. Johnson &amp; Johnson won the court case, and in 2009 Abbott was ordered to pay Johnson &amp; Johnson $1.17 billion in lost revenues and $504 million in royalties.<sup id="cite_ref-Bloomberg2009_133-0" class="reference"><a href="#cite_note-Bloomberg2009-133">[133]</a></sup> The judge also added $175.6 million in interest to bring the total to $1.84 billion.<sup id="cite_ref-bloomberg2010_134-0" class="reference"><a href="#cite_note-bloomberg2010-134">[134]</a></sup> This was the largest patent-infringement award in U.S. history<sup id="cite_ref-Bloomberg2009_133-1" class="reference"><a href="#cite_note-Bloomberg2009-133">[133]</a></sup> until the 2013 decision against Teva in favor of <a href="/wiki/Takeda" title="Takeda">Takeda</a> and <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> for over 2.1 billion dollars.<sup id="cite_ref-WSJ2013_135-0" class="reference"><a href="#cite_note-WSJ2013-135">[135]</a></sup> In 2010 Abbott appealed the verdict<sup id="cite_ref-bloomberg2010_134-1" class="reference"><a href="#cite_note-bloomberg2010-134">[134]</a></sup> and in 2011 won the appeal.<sup id="cite_ref-BusinessWeek2011_136-0" class="reference"><a href="#cite_note-BusinessWeek2011-136">[136]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Vaginal_mesh_implants">Vaginal mesh implants</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=36" title="Edit section: Vaginal mesh implants" data-section="36" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Tens of thousands of women worldwide have taken legal action against Johnson &amp; Johnson after suffering serious complications following a vaginal mesh implant procedure.<sup id="cite_ref-cbsnews.com_137-0" class="reference"><a href="#cite_note-cbsnews.com-137">[137]</a></sup> In 2016 the U.S. states of <a href="/wiki/California" title="California">California</a> and <a href="/wiki/Washington_(U.S._state)" class="mw-redirect" title="Washington (U.S. state)">Washington</a> filed a lawsuit against the company, accusing it of deception.<sup id="cite_ref-cbsnews.com_137-1" class="reference"><a href="#cite_note-cbsnews.com-137">[137]</a></sup> More than 700 women began a <a href="/wiki/Class_action" title="Class action">class action</a> against the company in the <a href="/wiki/Federal_Court_of_Australia" title="Federal Court of Australia">Federal Court of Australia</a> in 2017, telling the court they "suffered irreparable, debilitating pain after the devices began to erode into surrounding tissue and organs, causing infections and complications". The class action alleged that Johnson &amp; Johnson, which "aggressively marketed" the implants "failed to properly warn patients and surgeons of the risk, or test the devices adequately".<sup id="cite_ref-138" class="reference"><a href="#cite_note-138">[138]</a></sup> Emails between executives show the company was aware of the risks in 2005 but still went ahead and made the product available.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139">[139]</a></sup></p><p>In October 2019, the company and its subsidiary, Ethicon, Inc. reached a settlement with 41 states and the District of Columbia, with no admission of liability, in a suit alleging deceptive marketing of transvaginal surgical-mesh devices. The suit also alleges that the company failed to disclose risks associated with the product, which J&amp;J pulled from the market in 2012. The amount settled in the suit was about US$117 million.<sup id="cite_ref-140" class="reference"><a href="#cite_note-140">[140]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Baby_powder">Baby powder</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=37" title="Edit section: Baby powder" data-section="37" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>In February 2016, J&amp;J was ordered to pay $72 million in damages to the family of Jacqueline Fox, a 62-year-old woman who died of ovarian cancer in 2015: the company said it would appeal.<sup id="cite_ref-BBC_141-0" class="reference"><a href="#cite_note-BBC-141">[141]</a></sup></p><p>By March 2017, over 1,000 U.S. women had sued J&amp;J for covering up the possible cancer risk from its Baby Powder product; the company says that 70 percent of its Baby Powder is used by adults.<sup id="cite_ref-142" class="reference"><a href="#cite_note-142">[142]</a></sup></p><p>In August 2017, a California jury ordered Johnson &amp; Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene. The verdict included $70 million in compensatory damages and $347 million in punitive damages. J&amp;J said they will appeal the verdict.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143">[143]</a></sup></p><p>In October 2017, the <a href="/wiki/Missouri" title="Missouri">Missouri</a> Eastern District appeals court on Tuesday threw out a $72 million jury verdict. The appeals court ruled 3-0 that Jacqueline Fox's lawsuit lacked jurisdiction in Missouri because of a U.S. Supreme Court decision that imposed limits on where injury lawsuit can be filed which ". . . establishing a lawsuit's jurisdiction requires a stronger connection between the forum state and a plaintiff's claims."  Subsequently, this ruling would kill three other recent St. Louis jury verdicts of more than $200 million combined. Fox, 62, of <a href="/wiki/Birmingham,_Ala." class="mw-redirect" title="Birmingham, Ala.">Birmingham, Ala.</a>, died in 2015, about four months before her trial was held in <a href="/wiki/St._Louis" title="St. Louis">St. Louis</a> Circuit Court. She was among 65 plaintiffs, of whom only two were from Missouri.<sup id="cite_ref-144" class="reference"><a href="#cite_note-144">[144]</a></sup></p><p>In July 2018, a St. Louis jury awarded nearly US$4.7 billion in damages to 22 women and their families after they claimed asbestos in Johnson &amp; Johnson talcum powder caused their ovarian cancer.<sup id="cite_ref-145" class="reference"><a href="#cite_note-145">[145]</a></sup>  Conversely, in December 2019, a St. Louis jury ruled in favor of Johnson &amp; Johnson in the case of a single plaintiff who had used the company's talc-containing baby powder for thirty years with a similar claim.<sup id="cite_ref-146" class="reference"><a href="#cite_note-146">[146]</a></sup>  In 2019, the company's CEO, Alex Gorsky, declined to appear at a United States congressional hearing on the safety of the Johnson's and Johnson's Baby Powder and other talc-based cosmetics. J&amp;J spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a J&amp;J executive in charge of consumer products.<sup id="cite_ref-147" class="reference"><a href="#cite_note-147">[147]</a></sup></p><p>In August 2018, Johnson &amp; Johnson said that it removed several chemicals from baby powder products and re-engineered them to make consumers more confident that products were safer for children.<sup id="cite_ref-148" class="reference"><a href="#cite_note-148">[148]</a></sup></p><p>In December 2018, with 11,700 people suing Johnson &amp; Johnson over cancers allegedly caused by baby powder, the company was forced to release internal documents. The documents showed that the company had known about asbestos contamination since at least as early as 1971 and had spent decades finding ways to conceal the evidence from the public.<sup id="cite_ref-149" class="reference"><a href="#cite_note-149">[149]</a></sup> On December 19, the company lost its request to reverse a jury verdict that ruled in favor of the accusers, which required the company to pay $4.14 billion in punitive damages and $550 million in compensatory damages.<sup id="cite_ref-150" class="reference"><a href="#cite_note-150">[150]</a></sup> Though <a href="/wiki/Asbestos" title="Asbestos">asbestos</a> is a known <a href="/wiki/Carcinogen" title="Carcinogen">carcinogen</a>, the potential link between asbestos-free talc and cancer also alleged in these lawsuits is a subject of scientific controversy, as discussed on the Neurologica blog by <a href="/wiki/Steven_Novella" title="Steven Novella">Steven Novella</a>. A large study performed in 2003 found that ovarian cancer risk increased from a baseline of 0.0121% to 0.0161% in people who reported regularly using talc in the genital area. Two more studies over the next twelve years, which also relied on <a href="/wiki/Self-report" class="mw-redirect" title="Self-report">self-reporting</a>, had similar results. However, none of the three studies showed a relationship between how long someone used talc and how much their cancer risk increased, which is expected in experiments with carcinogens and other toxic substances (see <a href="/wiki/Dose-response_relationship" class="mw-redirect" title="Dose-response relationship">dose-response relationship</a>).<sup id="cite_ref-151" class="reference"><a href="#cite_note-151">[151]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Opioid_epidemic">Opioid epidemic</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=38" title="Edit section: Opioid epidemic" data-section="38" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Opioid_epidemic_in_the_United_States" title="Opioid epidemic in the United States">Opioid epidemic in the United States</a></div>
<p>By 2018, the company had become embroiled in the <a href="/wiki/Opioid_epidemic_in_the_United_States" title="Opioid epidemic in the United States">opioid epidemic in the United States</a> and had become a target of <a href="/wiki/Lawsuit" title="Lawsuit">lawsuits</a>.<sup id="cite_ref-152" class="reference"><a href="#cite_note-152">[152]</a></sup><sup id="cite_ref-153" class="reference"><a href="#cite_note-153">[153]</a></sup> Over 500 opioid-related cases have been filed as of May 2018 against Johnson &amp; Johnson and its competitors.<sup id="cite_ref-154" class="reference"><a href="#cite_note-154">[154]</a></sup> In Idaho, Johnson &amp; Johnson is part of a lawsuit accusing the company for being partially to blame for opioid-related overdose deaths.<sup id="cite_ref-155" class="reference"><a href="#cite_note-155">[155]</a></sup> The first major trial began in Oklahoma in May 2019.<sup id="cite_ref-156" class="reference"><a href="#cite_note-156">[156]</a></sup> On August 26, 2019, the Oklahoma judge ordered Johnson &amp; Johnson to pay $572 million for their part in the opioid crisis.<sup id="cite_ref-157" class="reference"><a href="#cite_note-157">[157]</a></sup> In October 2019, Johnson &amp; Johnson reached a $20.4 million settlement with two Ohio counties grappling with the opioid epidemic.<sup id="cite_ref-158" class="reference"><a href="#cite_note-158">[158]</a></sup></p>
<h4 class="in-block"><span class="mw-headline" id="Northeastern_Ohio_Settlement">Northeastern Ohio Settlement</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=39" title="Edit section: Northeastern Ohio Settlement" data-section="39" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h4>
<p>In October 2019, the company agreed to a settlement of US$20.4 million with two Ohio counties – Cuyahoga (Cleveland) and Summit (Akron). The settlement allows the company avoidance of a trial accusing J&amp;J and many other pharmaceutical manufacturers of helping to spark the US opioid epidemic. The trial, scheduled for October 2019, was thought to be an indicator for thousands of opioid-related lawsuits against many drug manufacturers. The arrangement, which contains no admission of liability by the company, provides the counties US$10 million in cash, $5 million for legal expenses and $5.4 million in contributions to opioid-related non-profit organizations in the counties.<sup id="cite_ref-159" class="reference"><a href="#cite_note-159">[159]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(9)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=40" title="Edit section: See also" data-section="40" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-9 collapsible-block" id="mf-section-9">
<style data-mw-deduplicate="TemplateStyles:r936637989">.mw-parser-output .portal{border:solid #aaa 1px;padding:0}.mw-parser-output .portal.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portal.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portal>ul{display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portal>ul>li{display:table-row}.mw-parser-output .portal>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portal>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}</style><div role="navigation" aria-label="Portals" class="noprint portal plainlist tright">
<ul><li><span><noscript><img alt="flag" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/92/Flag_of_New_Jersey.svg/32px-Flag_of_New_Jersey.svg.png" decoding="async" width="32" height="19" class="noviewer thumbborder" data-file-width="512" data-file-height="308"></noscript><span class="lazy-image-placeholder" style="width: 32px;height: 19px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/9/92/Flag_of_New_Jersey.svg/32px-Flag_of_New_Jersey.svg.png" data-alt="flag" data-width="32" data-height="19" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/92/Flag_of_New_Jersey.svg/48px-Flag_of_New_Jersey.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/92/Flag_of_New_Jersey.svg/64px-Flag_of_New_Jersey.svg.png 2x" data-class="noviewer thumbborder"> </span></span><span><a href="/wiki/Portal:New_Jersey" title="Portal:New Jersey">New Jersey portal</a></span></li>
<li><span><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png" decoding="async" width="28" height="28" class="noviewer" data-file-width="512" data-file-height="512"></noscript><span class="lazy-image-placeholder" style="width: 28px;height: 28px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png" data-alt="" data-width="28" data-height="28" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/42px-Industry5.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/56px-Industry5.svg.png 2x" data-class="noviewer"> </span></span><span><a href="/wiki/Portal:Companies" title="Portal:Companies">Companies portal</a></span></li>
<li><span><noscript><img alt="icon" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/12px-WHO_Rod.svg.png" decoding="async" width="12" height="28" class="noviewer" data-file-width="107" data-file-height="250"></noscript><span class="lazy-image-placeholder" style="width: 12px;height: 28px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/12px-WHO_Rod.svg.png" data-alt="icon" data-width="12" data-height="28" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/18px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/24px-WHO_Rod.svg.png 2x" data-class="noviewer"> </span></span><span><a href="/wiki/Portal:Medicine" title="Portal:Medicine">Medicine portal</a></span></li></ul></div>
<ul><li><a href="/wiki/Frederick_Barnett_Kilmer" title="Frederick Barnett Kilmer">Frederick Barnett Kilmer</a> – Director of Scientific Laboratories from 1889 to 1934.</li>
<li><a href="/wiki/Zodiac_(schooner)" title="Zodiac (schooner)"><i>Zodiac</i></a> – Historic schooner built for the Johnson family heirs.</li></ul><div style="clear:both;"></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(10)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=41" title="Edit section: References" data-section="41" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-10 collapsible-block" id="mf-section-10">
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references"><li id="cite_note-10-K_2019-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-10-K_2019_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-10-K_2019_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-10-K_2019_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-10-K_2019_1-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://johnsonandjohnson.gcs-web.com/node/46106/html#sBA61C6974B02514088A51D14F9CE0D03">"ANNUAL REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934(Form 10-K)"</a>. February 18, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">March 14,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ANNUAL+REPORT+PURSUANT+TO+SECTION+13+OF+THE+SECURITIES+EXCHANGE+ACT+OF+1934%28Form+10-K%29&amp;rft.date=2020-02-18&amp;rft_id=https%3A%2F%2Fjohnsonandjohnson.gcs-web.com%2Fnode%2F46106%2Fhtml%23sBA61C6974B02514088A51D14F9CE0D03&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-10-K_2097-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-10-K_2097_2-0">^</a></b></span> <span class="error mw-ext-cite-error" lang="en" dir="ltr">Cite error: The named reference <code>10-K 2097</code> was invoked but never defined (see the <a href="/wiki/Help:Cite_errors/Cite_error_references_no_text" title="Help:Cite errors/Cite error references no text">help page</a>).
</span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.marketwatch.com/investing/stock/jnj/profile">"Johnson &amp; Johnson Profile"</a>. <i>MarketWatch.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">March 14,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MarketWatch.com&amp;rft.atitle=Johnson+%26+Johnson+Profile&amp;rft_id=https%3A%2F%2Fwww.marketwatch.com%2Finvesting%2Fstock%2Fjnj%2Fprofile&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><cite class="citation web">anonymous. <a rel="nofollow" class="external text" href="http://www.jnjvc.com/about-us/our-history">"VisionCare Corporate - Our History"</a>. <i>jnjvc.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=jnjvc.com&amp;rft.atitle=VisionCare+Corporate+-+Our+History&amp;rft.au=anonymous&amp;rft_id=http%3A%2F%2Fwww.jnjvc.com%2Fabout-us%2Four-history&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160418084123/http://files.shareholder.com/downloads/JNJ/1709744668x0x881109/474857DD-8E67-43B1-BB38-0A9712D93545/2015_annual_report_.pdf">"Johnson &amp; Johnson 2015 Annual Report"</a> <span class="cs1-format">(PDF)</span>. www.jnj.com. February 24, 2016. Archived from <a rel="nofollow" class="external text" href="http://files.shareholder.com/downloads/JNJ/1709744668x0x881109/474857DD-8E67-43B1-BB38-0A9712D93545/2015_annual_report_.pdf">the original</a> <span class="cs1-format">(PDF)</span> on April 18, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">September 28,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+2015+Annual+Report&amp;rft.pub=www.jnj.com&amp;rft.date=2016-02-24&amp;rft_id=http%3A%2F%2Ffiles.shareholder.com%2Fdownloads%2FJNJ%2F1709744668x0x881109%2F474857DD-8E67-43B1-BB38-0A9712D93545%2F2015_annual_report_.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/healthcare-products">"Products"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Products&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fhealthcare-products&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/healthcare-products/consumer">"Consumer Health Products"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Consumer+Health+Products&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fhealthcare-products%2Fconsumer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/healthcare-products/medical-devices">"Medical Devices"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Medical+Devices&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fhealthcare-products%2Fmedical-devices&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/healthcare-products/prescription">"Pharmaceutical Products"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Pharmaceutical+Products&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fhealthcare-products%2Fprescription&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/our-heritage/the-story-behind-johnson-johnson-logo">"A Sign of the Times: The Story Behind Johnson &amp; Johnson's Iconic Logo - Johnson &amp; Johnson"</a>. <i>www.jnj.com</i>. September 25, 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.jnj.com&amp;rft.atitle=A+Sign+of+the+Times%3A+The+Story+Behind+Johnson+%26+Johnson%27s+Iconic+Logo+-+Johnson+%26+Johnson&amp;rft.date=2017-09-25&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Four-heritage%2Fthe-story-behind-johnson-johnson-logo&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><cite class="citation news">Horner, Shirley (February 15, 1987). <a rel="nofollow" class="external text" href="https://www.nytimes.com/1987/02/15/nyregion/about-books.html">"About Books"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 7,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=About+Books&amp;rft.date=1987-02-15&amp;rft.aulast=Horner&amp;rft.aufirst=Shirley&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1987%2F02%2F15%2Fnyregion%2Fabout-books.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation magazine"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=peMCAAAAMBAJ&amp;pg=PA129&amp;lpg=PA129&amp;dq=mary+lea+johnson+first+baby#v=onepage&amp;q=mary%20lea%20johnson%20first%20baby&amp;f=false">"Crazier then You and Me"</a>. <i>New York Magazine</i>. February 23, 1987. p. 129.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Magazine&amp;rft.atitle=Crazier+then+You+and+Me&amp;rft.pages=129&amp;rft.date=1987-02-23&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DpeMCAAAAMBAJ%26pg%3DPA129%26lpg%3DPA129%26dq%3Dmary%2Blea%2Bjohnson%2Bfirst%2Bbaby%23v%3Donepage%26q%3Dmary%2520lea%2520johnson%2520first%2520baby%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><cite class="citation web">Todd, Susan (April 26, 2012). <a rel="nofollow" class="external text" href="https://www.nj.com/business/2012/04/johnson_johnsons_new_ceo_empha.html">"Johnson &amp; Johnson's new CEO emphasizes company credo at shareholder's meeting"</a>. <i>NJ.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">March 13,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NJ.com&amp;rft.atitle=Johnson+%26+Johnson%27s+new+CEO+emphasizes+company+credo+at+shareholder%27s+meeting&amp;rft.date=2012-04-26&amp;rft.aulast=Todd&amp;rft.aufirst=Susan&amp;rft_id=https%3A%2F%2Fwww.nj.com%2Fbusiness%2F2012%2F04%2Fjohnson_johnsons_new_ceo_empha.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><cite class="citation web">Carmichael, Taylor (December 31, 2019). <a rel="nofollow" class="external text" href="https://www.fool.com/investing/2019/12/31/if-you-invested-10000-in-johnson-johnsons-ipo-this.aspx">"If You Invested $10,000 in Johnson &amp; Johnson's IPO, This Is How Much Money You'd Have Now"</a>. <i>fool.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">March 13,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=fool.com&amp;rft.atitle=If+You+Invested+%2410%2C000+in+Johnson+%26+Johnson%27s+IPO%2C+This+Is+How+Much+Money+You%27d+Have+Now&amp;rft.date=2019-12-31&amp;rft.aulast=Carmichael&amp;rft.aufirst=Taylor&amp;rft_id=https%3A%2F%2Fwww.fool.com%2Finvesting%2F2019%2F12%2F31%2Fif-you-invested-10000-in-johnson-johnsons-ipo-this.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><cite class="citation news">Singer, Natasha (June 3, 2010). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2010/06/04/business/04mcneil.html?pagewanted=print">"Robert L. McNeil Jr., Chemist Who Introduced Tylenol, Dies at 94"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 4,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Robert+L.+McNeil+Jr.%2C+Chemist+Who+Introduced+Tylenol%2C+Dies+at+94&amp;rft.date=2010-06-03&amp;rft.aulast=Singer&amp;rft.aufirst=Natasha&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F06%2F04%2Fbusiness%2F04mcneil.html%3Fpagewanted%3Dprint&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fda.gov/media/79212/download">"FDA: Establishment Inspection Report, McNeil Consumer Healthcare"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA%3A+Establishment+Inspection+Report%2C+McNeil+Consumer+Healthcare&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F79212%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:1-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Watson, R. (2003). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC286262">"Paul Janssen"</a>. <i>BMJ : British Medical Journal</i>. <b>327</b> (7426): 1290. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.327.7426.1290">10.1136/bmj.327.7426.1290</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC286262">286262</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ+%3A+British+Medical+Journal&amp;rft.atitle=Paul+Janssen&amp;rft.volume=327&amp;rft.issue=7426&amp;rft.pages=1290&amp;rft.date=2003&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC286262&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.327.7426.1290&amp;rft.aulast=Watson&amp;rft.aufirst=R.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC286262&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:2-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-:2_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Ban, Thomas A. (August 2004). "Paul Adriaan Jan Janssen, 1926–2003". <i>Neuropsychopharmacology</i>. <b>29</b> (8): 1579–1580. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fsj.npp.1300423">10.1038/sj.npp.1300423</a></span>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1740-634X">1740-634X</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.atitle=Paul+Adriaan+Jan+Janssen%2C+1926%E2%80%932003&amp;rft.volume=29&amp;rft.issue=8&amp;rft.pages=1579-1580&amp;rft.date=2004-08&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.npp.1300423&amp;rft.issn=1740-634X&amp;rft.aulast=Ban&amp;rft.aufirst=Thomas+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation news">Saxon, Wolfgang (November 13, 2003). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2003/11/13/business/dr-paul-janssen-77-dies-founder-of-a-drug-company.html">"Dr. Paul Janssen, 77, Dies; Founder of a Drug Company"</a>. <i>The New York Times</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0362-4331">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">February 11,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Dr.+Paul+Janssen%2C+77%2C+Dies%3B+Founder+of+a+Drug+Company&amp;rft.date=2003-11-13&amp;rft.issn=0362-4331&amp;rft.aulast=Saxon&amp;rft.aufirst=Wolfgang&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2003%2F11%2F13%2Fbusiness%2Fdr-paul-janssen-77-dies-founder-of-a-drug-company.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sdbj.com/news/2013/aug/20/jj-closes-aragon-pharmaceuticals-deal/">"J&amp;J Closes Aragon Pharmaceuticals Deal"</a>. <i>San Diego Business Journal</i><span class="reference-accessdate">. Retrieved <span class="nowrap">February 11,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=San+Diego+Business+Journal&amp;rft.atitle=J%26J+Closes+Aragon+Pharmaceuticals+Deal&amp;rft_id=https%3A%2F%2Fwww.sdbj.com%2Fnews%2F2013%2Faug%2F20%2Fjj-closes-aragon-pharmaceuticals-deal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.lifescienceleader.com/doc/alios-biopharma-from-startup-to-big-pharma-0001">"Alios BioPharma From Startup To Big Pharma"</a>. <i>www.lifescienceleader.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">February 11,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.lifescienceleader.com&amp;rft.atitle=Alios+BioPharma+From+Startup+To+Big+Pharma&amp;rft_id=https%3A%2F%2Fwww.lifescienceleader.com%2Fdoc%2Falios-biopharma-from-startup-to-big-pharma-0001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-completes-acquisition-of-micrus-endovascular-corporation-/">"Johnson &amp; Johnson Completes Acquisition of Micrus Endovascular Corporation"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Completes+Acquisition+of+Micrus+Endovascular+Corporation&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-completes-acquisition-of-micrus-endovascular-corporation-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnjmedicaldevices.com/en-US/news-events/johnson-johnson-announces-completion-synthes-acquisition">"Johnson &amp; Johnson Announces Completion of Synthes Acquisition | J&amp;J Medical Devices"</a>. <i>www.jnjmedicaldevices.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.jnjmedicaldevices.com&amp;rft.atitle=Johnson+%26+Johnson+Announces+Completion+of+Synthes+Acquisition+%26%23124%3B+J%26J+Medical+Devices&amp;rft_id=https%3A%2F%2Fwww.jnjmedicaldevices.com%2Fen-US%2Fnews-events%2Fjohnson-johnson-announces-completion-synthes-acquisition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/depuy-synthes-companies-acquires-olive-medical-corporation">"Depuy Synthes Companies Acquires Olive Medical Corporation | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Depuy+Synthes+Companies+Acquires+Olive+Medical+Corporation+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fdepuy-synthes-companies-acquires-olive-medical-corporation&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/depuy-synthes-companies-announces-acquisition-of-biomedical-enterprises-inc-a-leader-in-small-bone-fixation">"DePuy Synthes Companies Announces Acquisition Of Biomedical Enterprises, Inc., A Leader In Small Bone Fixation | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=DePuy+Synthes+Companies+Announces+Acquisition+Of+Biomedical+Enterprises%2C+Inc.%2C+A+Leader+In+Small+Bone+Fixation+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fdepuy-synthes-companies-announces-acquisition-of-biomedical-enterprises-inc-a-leader-in-small-bone-fixation&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/codman-neuro-announces-acquisition-of-pulsar-vascular-inc-expanding-neurovascular-treatment-for-patients-with-complex-aneurysms">"Codman Neuro Announces Acquisition Of Pulsar Vascular Inc., Expanding Neurovascular Treatment For Patients With Complex Aneurysms | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Codman+Neuro+Announces+Acquisition+Of+Pulsar+Vascular+Inc.%2C+Expanding+Neurovascular+Treatment+For+Patients+With+Complex+Aneurysms+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fcodman-neuro-announces-acquisition-of-pulsar-vascular-inc-expanding-neurovascular-treatment-for-patients-with-complex-aneurysms&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-s-depuy-synthes-buys-technology-from-interventional-spine-for-undisclosed-sum-/">"Johnson &amp; Johnson's DePuy Synthes Buys Technology From Interventional Spine for Undisclosed Sum"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson%27s+DePuy+Synthes+Buys+Technology+From+Interventional+Spine+for+Undisclosed+Sum&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-s-depuy-synthes-buys-technology-from-interventional-spine-for-undisclosed-sum-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><cite class="citation web">Ltd, Insider Media. <a rel="nofollow" class="external text" href="https://www.insidermedia.com/insider/ireland/johnson-johnson-moves-for-irish-medical-firm">"Johnson &amp; Johnson moves for Irish medical firm"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+moves+for+Irish+medical+firm&amp;rft.aulast=Ltd&amp;rft.aufirst=Insider+Media&amp;rft_id=https%3A%2F%2Fwww.insidermedia.com%2Finsider%2Fireland%2Fjohnson-johnson-moves-for-irish-medical-firm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation web">Coyle, Dominic. <a rel="nofollow" class="external text" href="https://www.irishtimes.com/business/health-pharma/johnson-johnson-buys-irish-stroke-care-firm-in-multimillion-euro-deal-1.3043551">"Johnson &amp; Johnson buys Irish stroke care firm in multimillion euro deal"</a>. <i>The Irish Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Irish+Times&amp;rft.atitle=Johnson+%26+Johnson+buys+Irish+stroke+care+firm+in+multimillion+euro+deal&amp;rft.aulast=Coyle&amp;rft.aufirst=Dominic&amp;rft_id=https%3A%2F%2Fwww.irishtimes.com%2Fbusiness%2Fhealth-pharma%2Fjohnson-johnson-buys-irish-stroke-care-firm-in-multimillion-euro-deal-1.3043551&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/depuy-synthes-announces-acquisition-of-sentio-llc-to-enable-innovation-in-minimally-invasive-spine-surgery">"DePuy Synthes Announces Acquisition of Sentio, LLC to Enable Innovation in Minimally Invasive Spine Surgery"</a>. <i>www.jnj.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.jnj.com&amp;rft.atitle=DePuy+Synthes+Announces+Acquisition+of+Sentio%2C+LLC+to+Enable+Innovation+in+Minimally+Invasive+Spine+Surgery&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fdepuy-synthes-announces-acquisition-of-sentio-llc-to-enable-innovation-in-minimally-invasive-spine-surgery&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-a-href-http-www-biospace-com-joblistingcompany-aspx-job_customer_entity_id-248231-and-source-newsjoblink-font-color-red-jobs-273389/">"Johnson &amp; Johnson (JOBS) to Acquire Cougar Biotechnology, Inc. for About $970 Million"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+%28JOBS%29+to+Acquire+Cougar+Biotechnology%2C+Inc.+for+About+%24970+Million&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-a-href-http-www-biospace-com-joblistingcompany-aspx-job_customer_entity_id-248231-and-source-newsjoblink-font-color-red-jobs-273389%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-begins-tender-offer-to-acquire-cougar-biotechnology-inc-/">"Johnson &amp; Johnson Begins Tender Offer to Acquire Cougar Biotechnology, Inc"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Begins+Tender+Offer+to+Acquire+Cougar+Biotechnology%2C+Inc.&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-begins-tender-offer-to-acquire-cougar-biotechnology-inc-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-nordic-ab-acquires-amic-gains-access-to-in-vitro-diagnostic-technologies-in-development-for-use-in-point-of-care-settings-/">"Johnson &amp; Johnson Nordic AB Acquires Amic Gains Access to In Vitro Diagnostic Technologies in Development for Use in Point-of-Care Settings"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Nordic+AB+Acquires+Amic+Gains+Access+to+In+Vitro+Diagnostic+Technologies+in+Development+for+Use+in+Point-of-Care+Settings&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-nordic-ab-acquires-amic-gains-access-to-in-vitro-diagnostic-technologies-in-development-for-use-in-point-of-care-settings-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20100605035200/http://www.infogrok.com/index.php/pharmaceutical/centocor-ortho-biotech-acquires-respivert.html">"Archived copy"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.infogrok.com/index.php/pharmaceutical/centocor-ortho-biotech-acquires-respivert.html">the original</a> on June 5, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">June 1,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.infogrok.com%2Findex.php%2Fpharmaceutical%2Fcentocor-ortho-biotech-acquires-respivert.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/janssen-joins-macrogenics-in-up-to-700m-cancer-collaboration/81250728/">"Janssen Joins MacroGenics in Up-to-$700M Cancer Collaboration"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Janssen+Joins+MacroGenics+in+Up-to-%24700M+Cancer+Collaboration&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fjanssen-joins-macrogenics-in-up-to-700m-cancer-collaboration%2F81250728%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/janssen-isis-pharma-ink-up-to-835m-antisense-agreement/81250763/">"Janssen, Isis Pharma Ink Up-to-$835M Antisense Agreement"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Janssen%2C+Isis+Pharma+Ink+Up-to-%24835M+Antisense+Agreement&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fjanssen-isis-pharma-ink-up-to-835m-antisense-agreement%2F81250763%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/janssen-to-acquire-benevir-biopharm-to-advance-immunotherapy-regimens">"Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Janssen+to+Acquire+BeneVir+Biopharm+to+Advance+Immunotherapy+Regimens&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fjanssen-to-acquire-benevir-biopharm-to-advance-immunotherapy-regimens&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.biospace.com/article/releases/xbiotech-announces-agreement-to-sell-true-human-antibody-bermekimab-targeting-il-1a-to-janssen/?s=79">https://www.biospace.com/article/releases/xbiotech-announces-agreement-to-sell-true-human-antibody-bermekimab-targeting-il-1a-to-janssen/?s=79</a></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.biospace.com/article/releases/janssen-to-acquire-investigational-bermekimab-from-xbiotech/?s=79">https://www.biospace.com/article/releases/janssen-to-acquire-investigational-bermekimab-from-xbiotech/?s=79</a></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160110154950/http://www.ethiconproducts.co.uk/about/ethicon-history">"ETHICON History"</a>. <i>www.ethiconproducts.co.uk</i>. Archived from <a rel="nofollow" class="external text" href="http://www.ethiconproducts.co.uk/about/ethicon-history">the original</a> on January 10, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">January 25,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ethiconproducts.co.uk&amp;rft.atitle=ETHICON+History&amp;rft_id=http%3A%2F%2Fwww.ethiconproducts.co.uk%2Fabout%2Fethicon-history&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.ethicon.com/corporate/our-commitment/history">"A history of advancing surgery"</a>. <i>www.ethicon.com</i>. Ethicon U.S., LLC<span class="reference-accessdate">. Retrieved <span class="nowrap">January 25,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ethicon.com&amp;rft.atitle=A+history+of+advancing+surgery&amp;rft_id=http%3A%2F%2Fwww.ethicon.com%2Fcorporate%2Four-commitment%2Fhistory&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20181213073432/http://www.investor.jnj.com/releasedetail.cfm?releaseid=351111">"Johnson &amp; Johnson Announces Definitive Agreement to Acquire Mentor Corporation"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.investor.jnj.com/releasedetail.cfm?releaseid=351111">the original</a> on December 13, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">February 3,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+Announces+Definitive+Agreement+to+Acquire+Mentor+Corporation&amp;rft_id=http%3A%2F%2Fwww.investor.jnj.com%2Freleasedetail.cfm%3Freleaseid%3D351111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-announces-receipt-of-israeli-antitrust-approval-for-acquisition-of-omrix-biopharmaceuticals-inc-/">"Johnson &amp; Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix Biopharmaceuticals, Inc"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Announces+Receipt+of+Israeli+Antitrust+Approval+for+Acquisition+of+Omrix+Biopharmaceuticals%2C+Inc.&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-announces-receipt-of-israeli-antitrust-approval-for-acquisition-of-omrix-biopharmaceuticals-inc-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-a-href-http-www-biospace-com-joblistingcompany-aspx-job_customer_entity_id-248231-and-source-newsjoblink-font-color-red-jobs-f237653/">"Johnson &amp; Johnson (JOBS) Acquire Omrix Biopharmaceuticals, Inc. for $438 Million"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+%28JOBS%29+Acquire+Omrix+Biopharmaceuticals%2C+Inc.+for+%24438+Million&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-a-href-http-www-biospace-com-joblistingcompany-aspx-job_customer_entity_id-248231-and-source-newsjoblink-font-color-red-jobs-f237653%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-acquires-medical-device-maker-in-china-/">"Johnson &amp; Johnson Acquires Medical Device Maker in China"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Acquires+Medical+Device+Maker+in+China&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-acquires-medical-device-maker-in-china-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160311015712/http://www.fiercemedicaldevices.com/press-releases/ethicon-announces-agreement-acquire-neuwave-medical-inc">"Ethicon Announces Agreement To Acquire NeuWave Medical, Inc"</a>. <i>FierceMedicalDevices</i>. Archived from <a rel="nofollow" class="external text" href="http://www.fiercemedicaldevices.com/press-releases/ethicon-announces-agreement-acquire-neuwave-medical-inc">the original</a> on March 11, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FierceMedicalDevices&amp;rft.atitle=Ethicon+Announces+Agreement+To+Acquire+NeuWave+Medical%2C+Inc.&amp;rft_id=http%3A%2F%2Fwww.fiercemedicaldevices.com%2Fpress-releases%2Fethicon-announces-agreement-acquire-neuwave-medical-inc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/ethicon-announces-acquisition-of-megadyne-medical-products-inc">"Ethicon Announces Acquisition of Megadyne Medical Products, Inc. | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Ethicon+Announces+Acquisition+of+Megadyne+Medical+Products%2C+Inc.+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fethicon-announces-acquisition-of-megadyne-medical-products-inc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.startribune.com/johnson-amp-johnson-subsidiary-buys-torax-medical/414280943/">"Johnson &amp; Johnson subsidiary buys Torax Medical"</a>. <i>Star Tribune</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Star+Tribune&amp;rft.atitle=Johnson+%26+Johnson+subsidiary+buys+Torax+Medical&amp;rft_id=http%3A%2F%2Fwww.startribune.com%2Fjohnson-amp-johnson-subsidiary-buys-torax-medical%2F414280943%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-binding-offer-from-fortive-corporation-to-acquire-advanced-sterilization-products-asp">"Johnson &amp; Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP)"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Johnson+%26+Johnson+Announces+Binding+Offer+from+Fortive+Corporation+to+Acquire+Advanced+Sterilization+Products+%28ASP%29&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fjohnson-johnson-announces-binding-offer-from-fortive-corporation-to-acquire-advanced-sterilization-products-asp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-auris-m-a-johnson-johnson-idUKKCN1Q21QI">"Johnson &amp; Johnson to buy surgical robotics firm Auris for $3.4 billion"</a>. February 13, 2019 – via uk.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+to+buy+surgical+robotics+firm+Auris+for+%243.4+billion&amp;rft.date=2019-02-13&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-auris-m-a-johnson-johnson-idUKKCN1Q21QI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-snaps-up-surgical-robotics-company-auris-health-for-3-4-billion/">"Johnson &amp; Johnson Snaps up Surgical Robotics Company Auris Health for $3.4 Billion"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Snaps+up+Surgical+Robotics+Company+Auris+Health+for+%243.4+Billion&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-snaps-up-surgical-robotics-company-auris-health-for-3-4-billion%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/johnson-johnson-announces-agreement-to-acquire-auris-health-inc">"Johnson &amp; Johnson Announces Agreement to Acquire Auris Health, Inc. | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Johnson+%26+Johnson+Announces+Agreement+to+Acquire+Auris+Health%2C+Inc.+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fjohnson-johnson-announces-agreement-to-acquire-auris-health-inc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://uk.reuters.com/article/uk-verb-surgical-m-a-johnson-johnson/jj-to-buy-remaining-stake-in-verb-surgical-to-strengthen-digital-surgery-portfolio-idUKKBN1YO1GR">https://uk.reuters.com/article/uk-verb-surgical-m-a-johnson-johnson/jj-to-buy-remaining-stake-in-verb-surgical-to-strengthen-digital-surgery-portfolio-idUKKBN1YO1GR</a></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/ethicon-endo-surgery-inc-completes-acquisition-of-surgrx-inc-/">"Ethicon Endo-Surgery, Inc. Completes Acquisition of SurgRx, Inc"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Ethicon+Endo-Surgery%2C+Inc.+Completes+Acquisition+of+SurgRx%2C+Inc.&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fethicon-endo-surgery-inc-completes-acquisition-of-surgrx-inc-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/ethicon-endo-surgery-inc-to-acquire-b-sterilmed-b-/">"Ethicon Endo-Surgery, Inc. to Acquire SterilMed"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Ethicon+Endo-Surgery%2C+Inc.+to+Acquire+SterilMed&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fethicon-endo-surgery-inc-to-acquire-b-sterilmed-b-%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:0-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_56-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Johnson, Linda A. (January 24, 2018). <a rel="nofollow" class="external text" href="https://www.dddmag.com/news/2018/01/johnson-johnson-loses-107-b-after-sweeping-us-tax-changes">"Johnson &amp; Johnson Loses $10.7 B After Sweeping U.S. Tax Changes"</a>. <i>Drug Discovery &amp; Development Magazine</i>. Associated Press<span class="reference-accessdate">. Retrieved <span class="nowrap">January 24,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Discovery+%26+Development+Magazine&amp;rft.atitle=Johnson+%26+Johnson+Loses+%2410.7+B+After+Sweeping+U.S.+Tax+Changes&amp;rft.date=2018-01-24&amp;rft.aulast=Johnson&amp;rft.aufirst=Linda+A.&amp;rft_id=https%3A%2F%2Fwww.dddmag.com%2Fnews%2F2018%2F01%2Fjohnson-johnson-loses-107-b-after-sweeping-us-tax-changes&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-actelion-johnson-johnson-idUSKBN15A0KM">"Johnson &amp; Johnson to buy Actelion for $30 billion, spin off R&amp;D unit"</a>. <i>Reuters</i>. January 26, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">January 26,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Johnson+%26+Johnson+to+buy+Actelion+for+%2430+billion%2C+spin+off+R%26D+unit&amp;rft.date=2017-01-26&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-actelion-johnson-johnson-idUSKBN15A0KM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-wsj-rockoff-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-wsj-rockoff_58-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFRolandD._Rockoff2017" class="citation">Roland, Denise; D. Rockoff, Jonathan (January 26, 2017), <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/johnson-johnson-to-acquire-rare-disease-drug-maker-actelion-in-30-billion-deal-1485413057"><i>Johnson &amp; Johnson to Acquire Actelion in $30 Billion Deal</i></a>, Wall Street Journal<span class="reference-accessdate">, retrieved <span class="nowrap">January 27,</span> 2017</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Johnson+%26+Johnson+to+Acquire+Actelion+in+%2430+Billion+Deal&amp;rft.pub=Wall+Street+Journal&amp;rft.date=2017-01-26&amp;rft.aulast=Roland&amp;rft.aufirst=Denise&amp;rft.au=D.+Rockoff%2C+Jonathan&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fjohnson-johnson-to-acquire-rare-disease-drug-maker-actelion-in-30-billion-deal-1485413057&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/brief-johnson-johnson-says-janssen-holdi-idUSFWN1H800N">"BRIEF-Johnson &amp; Johnson says Janssen Holding to acquire all publicly held shares of Actelion for $280 per share"</a>. March 31, 2017 – via Reuters.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BRIEF-Johnson+%26+Johnson+says+Janssen+Holding+to+acquire+all+publicly+held+shares+of+Actelion+for+%24280+per+share&amp;rft.date=2017-03-31&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fbrief-johnson-johnson-says-janssen-holdi-idUSFWN1H800N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-johnson-johnson-m-a-actelion-idUSKBN1720G1">"J&amp;J declares Actelion tender offer a success, sees closing in second quarter"</a>. March 31, 2017 – via Reuters.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=J%26J+declares+Actelion+tender+offer+a+success%2C+sees+closing+in+second+quarter&amp;rft.date=2017-03-31&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-johnson-johnson-m-a-actelion-idUSKBN1720G1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.streetinsider.com/Corporate+News/Johnson+&amp;+Johnson+(JNJ)+Declares+%2430B+Actelion+Tender+Successful;+Controls+77.%25+of+Voting+Rights/12727694.html">"Johnson &amp; Johnson (JNJ) Declares $30B Actelion Tender Successful; Controls 77.% of Voting Rights"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+%28JNJ%29+Declares+%2430B+Actelion+Tender+Successful%3B+Controls+77.%25+of+Voting+Rights&amp;rft_id=https%3A%2F%2Fwww.streetinsider.com%2FCorporate%2BNews%2FJohnson%2B%26%2BJohnson%2B%28JNJ%29%2BDeclares%2B%2430B%2BActelion%2BTender%2BSuccessful%3B%2BControls%2B77.%2525%2Bof%2BVoting%2BRights%2F12727694.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-completion-of-acquisition-of-vogue-international-llc">"Johnson &amp; Johnson Announces Completion of Acquisition of Vogue International LLC | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Johnson+%26+Johnson+Announces+Completion+of+Acquisition+of+Vogue+International+LLC+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fjohnson-johnson-announces-completion-of-acquisition-of-vogue-international-llc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-agreement-to-acquire-abbott-medical-optics">"Johnson &amp; Johnson Announces Agreement to Acquire Abbott Medical Optics | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Johnson+%26+Johnson+Announces+Agreement+to+Acquire+Abbott+Medical+Optics+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fjohnson-johnson-announces-agreement-to-acquire-abbott-medical-optics&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7B7e870caf-5bbe-4645-84e0-f02be6f15139%7D/johnson--johnson-vision-to-acquire-tearscience">"Johnson &amp; Johnson Vision to acquire TearScience"</a>. <i>www.healio.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.healio.com&amp;rft.atitle=Johnson+%26+Johnson+Vision+to+acquire+TearScience&amp;rft_id=https%3A%2F%2Fwww.healio.com%2Fophthalmology%2Fophthalmic-business%2Fnews%2Fonline%2F%257B7e870caf-5bbe-4645-84e0-f02be6f15139%257D%2Fjohnson--johnson-vision-to-acquire-tearscience&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.geekwire.com/2017/johnson-johnson-acquires-subscription-based-contact-lens-startup-sightbox/">"Johnson &amp; Johnson acquires subscription-based contact lens startup Sightbox"</a>. September 19, 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+acquires+subscription-based+contact+lens+startup+Sightbox&amp;rft.date=2017-09-19&amp;rft_id=https%3A%2F%2Fwww.geekwire.com%2F2017%2Fjohnson-johnson-acquires-subscription-based-contact-lens-startup-sightbox%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><cite class="citation web">Research, National Center for Toxicological (March 18, 2019). <a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/fda-clears-first-contact-lens-light-adaptive-technology">"FDA clears first contact lens with light-adaptive technology"</a>. <i>FDA</i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 2,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FDA&amp;rft.atitle=FDA+clears+first+contact+lens+with+light-adaptive+technology&amp;rft.date=2019-03-18&amp;rft.aulast=Research&amp;rft.aufirst=National+Center+for+Toxicological&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-clears-first-contact-lens-light-adaptive-technology&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><cite class="citation web">Eva von Schaper; Ellen Gibson (October 6, 2010). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/articles/2010-10-06/johnson-johnson-crucell-reach-agreement-on-takeover-offer">"J&amp;J, Crucell Reach Agreement on $2.4 Billion Takeover"</a>. <i>Bloomberg.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Bloomberg.com&amp;rft.atitle=J%26J%2C+Crucell+Reach+Agreement+on+%242.4+Billion+Takeover&amp;rft.date=2010-10-06&amp;rft.au=Eva+von+Schaper&amp;rft.au=Ellen+Gibson&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2010-10-06%2Fjohnson-johnson-crucell-reach-agreement-on-takeover-offer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-johnson-completes-tender-offer-for-crucell-n-v-and-declares-offer-unconditional-378936/">"Johnson &amp; Johnson Completes Tender Offer for Crucell N.V. and Declares Offer Unconditional"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Completes+Tender+Offer+for+Crucell+N.V.+and+Declares+Offer+Unconditional&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-johnson-completes-tender-offer-for-crucell-n-v-and-declares-offer-unconditional-378936%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/biosense-webster-inc-announces-acquisition-of-coherex-medical-inc">"Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc. | Johnson &amp; Johnson"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Biosense+Webster%2C+Inc.+Announces+Acquisition+of+Coherex+Medical%2C+Inc.+%26%23124%3B+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fbiosense-webster-inc-announces-acquisition-of-coherex-medical-inc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc">"Johnson &amp; Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc"</a>. <i>Content Lab - U.S</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Content+Lab+-+U.S.&amp;rft.atitle=Johnson+%26+Johnson+Announces+Binding+Offer+from+Platinum+Equity+to+Acquire+LifeScan%2C+Inc.&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fjohnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/johnson-and-amp-johnson-medical-gmbh-acquires-emerging-implant-technologies-gmbh-to-enhance-global-offering-of-interbody-spine-implants/">"Johnson &amp; Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine Implants"</a>. <i>BioSpace</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Johnson+%26+Johnson+Medical+GmbH+Acquires+Emerging+Implant+Technologies+GmbH+to+Enhance+Global+Offering+of+Interbody+Spine+Implants&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Fjohnson-and-amp-johnson-medical-gmbh-acquires-emerging-implant-technologies-gmbh-to-enhance-global-offering-of-interbody-spine-implants%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/revenue">"Johnson &amp; Johnson Revenue 2006–2018 | JNJ"</a>. <i>www.macrotrends.net</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 28,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.macrotrends.net&amp;rft.atitle=Johnson+%26+Johnson+Revenue+2006%E2%80%932018+%7C+JNJ&amp;rft_id=https%3A%2F%2Fwww.macrotrends.net%2Fstocks%2Fcharts%2FJNJ%2Fjohnson-johnson%2Frevenue&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://de.statista.com/statistik/daten/studie/254345/umfrage/mitarbeiter-von-johnson-und-johnson-seit-2004/">"Johnson &amp; Johnson - Mitarbeiter bis 2017 | Statistik"</a>. <i>Statista</i> (in German)<span class="reference-accessdate">. Retrieved <span class="nowrap">December 9,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Statista&amp;rft.atitle=Johnson+%26+Johnson+-+Mitarbeiter+bis+2017+%7C+Statistik&amp;rft_id=https%3A%2F%2Fde.statista.com%2Fstatistik%2Fdaten%2Fstudie%2F254345%2Fumfrage%2Fmitarbeiter-von-johnson-und-johnson-seit-2004%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Johnson_&amp;_Johnson_Board_of_Directors-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Johnson_&amp;_Johnson_Board_of_Directors_74-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.jnj.com/leadership/our-leadership-team#board-of-directors">"Our Leadership Team"</a>. <i>Johnson &amp; Johnson</i>. Johnson &amp; Johnson<span class="reference-accessdate">. Retrieved <span class="nowrap">August 29,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Johnson+%26+Johnson&amp;rft.atitle=Our+Leadership+Team&amp;rft_id=https%3A%2F%2Fwww.jnj.com%2Fleadership%2Four-leadership-team%23board-of-directors&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.jnj.com/our-news-center/senior-management">"Our Leadership Team"</a>. Johnson &amp; Johnson.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Our+Leadership+Team&amp;rft.pub=Johnson+%26+Johnson&amp;rft_id=http%3A%2F%2Fwww.jnj.com%2Four-news-center%2Fsenior-management&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Verifiability#Self-published_sources" title="Wikipedia:Verifiability"><span title="This reference citation appears to be to a self-published source. (January 2018)">self-published source</span></a></i>]</sup></span>
</li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><cite class="citation web">Palmer, Eric. <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/johnson-johnson-shakeup-leaves-joaquin-duato-largest-portfolio">"Johnson &amp; Johnson shakeup leaves Joaquin Duato with largest portfolio"</a>. <i>FiercePharma</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Johnson+%26+Johnson+shakeup+leaves+Joaquin+Duato+with+largest+portfolio&amp;rft.aulast=Palmer&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fjohnson-johnson-shakeup-leaves-joaquin-duato-largest-portfolio&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://query.nytimes.com/gst/fullpage.html?res=F00714FC345D167493CBA9178CD85F438785F9">2 Long-Disputed Projects to Begin</a>, <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>, July 9, 1977</span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://query.nytimes.com/gst/fullpage.html?res=FA0914FC355F167493C4A8178FD85F438785F9">Old Raritan Canal Lock Is Focus of a Classic Dispute</a>, <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>, April 16, 1977.</span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130530111717/http://www.parliament.nsw.gov.au/prod/parlment/hansart.nsf/V3Key/LC20020314023">"JOHNSON &amp; JOHNSON ASIA-PACIFIC INFORMATION TECHNOLOGY HEADQUARTERS"</a>. March 14, 2002. Archived from <a rel="nofollow" class="external text" href="http://www.parliament.nsw.gov.au/prod/parlment/hansart.nsf/V3Key/LC20020314023">the original</a> on May 30, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">July 15,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=JOHNSON+%26+JOHNSON+ASIA-PACIFIC+INFORMATION+TECHNOLOGY+HEADQUARTERS&amp;rft.date=2002-03-14&amp;rft_id=http%3A%2F%2Fwww.parliament.nsw.gov.au%2Fprod%2Fparlment%2Fhansart.nsf%2FV3Key%2FLC20020314023&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://files.shareholder.com/downloads/JNJ/1709744668x0x881109/474857DD-8E67-43B1-BB38-0A9712D93545/2015_annual_report_.pdf">"Downloads"</a> <span class="cs1-format">(PDF)</span>. <i>files.shareholder.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=files.shareholder.com&amp;rft.atitle=Downloads&amp;rft_id=http%3A%2F%2Ffiles.shareholder.com%2Fdownloads%2FJNJ%2F1709744668x0x881109%2F474857DD-8E67-43B1-BB38-0A9712D93545%2F2015_annual_report_.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103772s5359lbl.pdf">"www.accessdata.fda.gov"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=www.accessdata.fda.gov&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2013%2F103772s5359lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125261s114lbl.pdf">"www.accessdata.fda.gov"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=www.accessdata.fda.gov&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2014%2F125261s114lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kaplan G, Casoy J, Zummo J (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3833623">"Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia"</a>. <i>Patient Prefer Adherence</i>. <b>7</b>: 1171–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FPPA.S53795">10.2147/PPA.S53795</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3833623">3833623</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24265549">24265549</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Patient+Prefer+Adherence&amp;rft.atitle=Impact+of+long-acting+injectable+antipsychotics+on+medication+adherence+and+clinical%2C+functional%2C+and+economic+outcomes+of+schizophrenia&amp;rft.volume=7&amp;rft.pages=1171-80&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3833623&amp;rft_id=info%3Apmid%2F24265549&amp;rft_id=info%3Adoi%2F10.2147%2FPPA.S53795&amp;rft.aulast=Kaplan&amp;rft.aufirst=G&amp;rft.au=Casoy%2C+J&amp;rft.au=Zummo%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3833623&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kane JM, Kishimoto T, Correll CU (August 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3742035">"Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry"</a>. <i>J Clin Epidemiol</i>. <b>66</b> (8 Suppl): S37–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jclinepi.2013.01.012">10.1016/j.jclinepi.2013.01.012</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3742035">3742035</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23849151">23849151</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Epidemiol&amp;rft.atitle=Assessing+the+comparative+effectiveness+of+long-acting+injectable+vs.+oral+antipsychotic+medications+in+the+prevention+of+relapse+provides+a+case+study+in+comparative+effectiveness+research+in+psychiatry&amp;rft.volume=66&amp;rft.issue=8+Suppl&amp;rft.pages=S37-41&amp;rft.date=2013-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3742035&amp;rft_id=info%3Apmid%2F23849151&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jclinepi.2013.01.012&amp;rft.aulast=Kane&amp;rft.aufirst=JM&amp;rft.au=Kishimoto%2C+T&amp;rft.au=Correll%2C+CU&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3742035&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><cite class="citation journal">Fusar-Poli P, Kempton MJ, Rosenheck RA (March 2013). "Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials". <i>Int Clin Psychopharmacol</i>. <b>28</b> (2): 57–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FYIC.0b013e32835b091f">10.1097/YIC.0b013e32835b091f</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23165366">23165366</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int+Clin+Psychopharmacol&amp;rft.atitle=Efficacy+and+safety+of+second-generation+long-acting+injections+in+schizophrenia%3A+a+meta-analysis+of+randomized-controlled+trials&amp;rft.volume=28&amp;rft.issue=2&amp;rft.pages=57-66&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1097%2FYIC.0b013e32835b091f&amp;rft_id=info%3Apmid%2F23165366&amp;rft.aulast=Fusar-Poli&amp;rft.aufirst=P&amp;rft.au=Kempton%2C+MJ&amp;rft.au=Rosenheck%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021602s031s032lbl.pdf">"www.accessdata.fda.gov"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=www.accessdata.fda.gov&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2012%2F021602s031s032lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202379s009lbl.pdf">"www.accessdata.fda.gov"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=www.accessdata.fda.gov&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2014%2F202379s009lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://abcnews.go.com/Health/wireStory/fda-approves-tuberculosis-40-years-18100650#.UOIPT-RQWe0">"FDA Approves 1st New Tuberculosis Drug in 40 Years"</a>. ABC News<span class="reference-accessdate">. Retrieved <span class="nowrap">December 31,</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+1st+New+Tuberculosis+Drug+in+40+Years&amp;rft.pub=ABC+News&amp;rft_id=http%3A%2F%2Fabcnews.go.com%2FHealth%2FwireStory%2Ffda-approves-tuberculosis-40-years-18100650%23.UOIPT-RQWe0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biopharmadive.com/news/johnson-janssen-hep-c-program-ending/504661/">"J&amp;J moves away from hep C due to rival drugmakers' cures"</a>. <i>BioPharma Dive</i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 18,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioPharma+Dive&amp;rft.atitle=J%26J+moves+away+from+hep+C+due+to+rival+drugmakers%27+cures&amp;rft_id=https%3A%2F%2Fwww.biopharmadive.com%2Fnews%2Fjohnson-janssen-hep-c-program-ending%2F504661%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biopharmadive.com/news/where-does-jjs-new-drug-fit-in-the-crowded-hiv-market/528076/">"Where does J&amp;J's new drug fit in the crowded HIV market?"</a>. <i>BioPharma Dive</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioPharma+Dive&amp;rft.atitle=Where+does+J%26J%27s+new+drug+fit+in+the+crowded+HIV+market%3F&amp;rft_id=https%3A%2F%2Fwww.biopharmadive.com%2Fnews%2Fwhere-does-jjs-new-drug-fit-in-the-crowded-hiv-market%2F528076%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm">"www.fda.gov"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=www.fda.gov&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm632761.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.janssencarepath.com/hcp/spravato">"www.janssencarepath.com"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=www.janssencarepath.com&amp;rft_id=https%3A%2F%2Fwww.janssencarepath.com%2Fhcp%2Fspravato&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.jnj.com/healthcare-products/medical-technologies">"Healthcare products - Medical technologies"</a>. <i>jnj.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">March 13,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=jnj.com&amp;rft.atitle=Healthcare+products+-+Medical+technologies&amp;rft_id=http%3A%2F%2Fwww.jnj.com%2Fhealthcare-products%2Fmedical-technologies&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.jnj.com/healthcare-products/consumer">"Healthcare products - consumer"</a>. <i>jnj.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">March 13,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=jnj.com&amp;rft.atitle=Healthcare+products+-+consumer&amp;rft_id=http%3A%2F%2Fwww.jnj.com%2Fhealthcare-products%2Fconsumer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20091010035720/http://greenrankings.newsweek.com//">"Green Rankings"</a>. Archived from <a rel="nofollow" class="external text" href="http://greenrankings.newsweek.com/">the original</a> on October 10, 2009.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Green+Rankings&amp;rft_id=http%3A%2F%2Fgreenrankings.newsweek.com%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20080502231556/http://www.jnj.com/connect/caring/environment-protection/environment-performance/">"Johnson &amp; Johnson Official Site"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.jnj.com/connect/caring/environment-protection/environment-performance/">the original</a> on May 2, 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">May 4,</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+Official+Site&amp;rft_id=http%3A%2F%2Fwww.jnj.com%2Fconnect%2Fcaring%2Fenvironment-protection%2Fenvironment-performance%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-ens-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-ens_97-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.ens-newswire.com/ens/dec2004/2004-12-08-09.asp">Environment New Service</a>, December 8, 2004. Retrieved May 4, 2008</span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20080426010045/http://www.coopamerica.org/programs/rs/profile.cfm?id=246">"Coop America"</a>. March 27, 2008. Archived from <a rel="nofollow" class="external text" href="http://www.coopamerica.org/programs/rs/profile.cfm?id=246">the original</a> on April 26, 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">May 4,</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coop+America&amp;rft.date=2008-03-27&amp;rft_id=http%3A%2F%2Fwww.coopamerica.org%2Fprograms%2Frs%2Fprofile.cfm%3Fid%3D246&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.depweb.state.pa.us/energy/cwp/view.asp?a=1370&amp;Q=494917">"Department of Environmental Protection"</a>. Commonwealth of Pennsylvania.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Department+of+Environmental+Protection&amp;rft.pub=Commonwealth+of+Pennsylvania&amp;rft_id=http%3A%2F%2Fwww.depweb.state.pa.us%2Fenergy%2Fcwp%2Fview.asp%3Fa%3D1370%26Q%3D494917&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-nytrecall-100"><span class="mw-cite-backlink">^ <a href="#cite_ref-nytrecall_100-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nytrecall_100-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Judith Rehak (March 23, 2002). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2002/03/23/your-money/23iht-mjj_ed3_.html">"Tylenol made a hero of Johnson &amp; Johnson : The recall that started them all"</a>. <i>The New York Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Tylenol+made+a+hero+of+Johnson+%26+Johnson+%3A+The+recall+that+started+them+all&amp;rft.date=2002-03-23&amp;rft.au=Judith+Rehak&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2002%2F03%2F23%2Fyour-money%2F23iht-mjj_ed3_.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.latimes.com/business/la-fi-lazarus11-2010feb11,0,3768807.column">Toyota, what's so hard about doing the right thing?</a>, <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i>, February 11, 2010</span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text">Jennifer Latson for Time Magazine Sept. 29, 2014 <a rel="nofollow" class="external text" href="http://time.com/3423136/tylenol-deaths-1982/">How Poisoned Tylenol Became a Crisis-Management Teaching Model</a></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text">Judith Rehak for The New York Times. March 23, 2002 <a rel="nofollow" class="external text" href="https://www.nytimes.com/2002/03/23/your-money/23iht-mjj_ed3_.html">Tylenol made a hero of Johnson &amp; Johnson : The recall that started them all</a></span>
</li>
<li id="cite_note-US_firm_recalls_children's_drugs-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-US_firm_recalls_children's_drugs_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-US_firm_recalls_children's_drugs_104-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-US_firm_recalls_children's_drugs_104-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://english.aljazeera.net/news/americas/2010/05/2010518535960539.html">"US firm recalls children's drugs"</a>. <i>Aljazeera</i>. May 1, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">May 3,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Aljazeera&amp;rft.atitle=US+firm+recalls+children%27s+drugs&amp;rft.date=2010-05-01&amp;rft_id=http%3A%2F%2Fenglish.aljazeera.net%2Fnews%2Famericas%2F2010%2F05%2F2010518535960539.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Warning_As_Baby_Medicines_Are_Recalled-105"><span class="mw-cite-backlink">^ <a href="#cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Warning_As_Baby_Medicines_Are_Recalled_105-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Watts, Alex (May 2, 2010). <a rel="nofollow" class="external text" href="http://news.sky.com/skynews/Home/World-News/Baby-Medicines-Massive-Recall-Of-Johnson--Johnson-Products-Made-By-McNeil-Consumer-Healthcare/Article/201005115623926?lpos=World_News_Top_Stories_Header_3&amp;lid=ARTICLE_15623926_Baby_Medicines%3A_Massive_Recall_Of_Johnson__Johnson_Products_Made_By_McNeil_Consumer_Healthcare">"Warning As Baby Medicines Are Recalled"</a>. <i>Sky News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 3,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Sky+News&amp;rft.atitle=Warning+As+Baby+Medicines+Are+Recalled&amp;rft.date=2010-05-02&amp;rft.aulast=Watts&amp;rft.aufirst=Alex&amp;rft_id=http%3A%2F%2Fnews.sky.com%2Fskynews%2FHome%2FWorld-News%2FBaby-Medicines-Massive-Recall-Of-Johnson--Johnson-Products-Made-By-McNeil-Consumer-Healthcare%2FArticle%2F201005115623926%3Flpos%3DWorld_News_Top_Stories_Header_3%26lid%3DARTICLE_15623926_Baby_Medicines%253A_Massive_Recall_Of_Johnson__Johnson_Products_Made_By_McNeil_Consumer_Healthcare&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Out_of_joint-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-Out_of_joint_106-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Deborah Cohen (May 14, 2011). <a rel="nofollow" class="external text" href="http://www.bmj.com/content/342/bmj.d2905.full">"Out of joint: The story of the ASR"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Out+of+joint%3A+The+story+of+the+ASR&amp;rft.date=2011-05-14&amp;rft.au=Deborah+Cohen&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcontent%2F342%2Fbmj.d2905.full&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-fda1-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-fda1_107-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm">"FDA. Concerns about metal-on-metal hip implant systems. 2011"</a>. 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=FDA.+Concerns+about+metal-on-metal+hip+implant+systems.+2011&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FMedicalDevices%2FProductsandMedicalProcedures%2FImplantsandProsthetics%2FMetalonMetalHipImplants%2Fucm241604.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Meier-108"><span class="mw-cite-backlink">^ <a href="#cite_ref-Meier_108-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Meier_108-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Meier, Barry (March 8, 2013). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2013/03/09/business/johnson-johnson-must-pay-in-first-hip-implant-case.html">"J.&amp;J. Loses First Case Over Faulty Hip Implant"</a>. <i>New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 4,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=J.%26J.+Loses+First+Case+Over+Faulty+Hip+Implant&amp;rft.date=2013-03-08&amp;rft.aulast=Meier&amp;rft.aufirst=Barry&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F03%2F09%2Fbusiness%2Fjohnson-johnson-must-pay-in-first-hip-implant-case.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-WebMd-109"><span class="mw-cite-backlink">^ <a href="#cite_ref-WebMd_109-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WebMd_109-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://arthritis.webmd.com/news/20091229/tylenol-recall-expands">Tylenol Recall Expands</a>, WebMD Health News, January 18, 2010</span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fda.gov/Safety/Recalls/ucm261498.htm/">"McNeil Consumer Healthcare Announces Voluntary Recall Of One Product Lot Of TYLENOL® Extra Strength Caplets 225 Count Distributed In The U.S."</a></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=McNeil+Consumer+Healthcare+Announces+Voluntary+Recall+Of+One+Product+Lot+Of+TYLENOL%C2%AE+Extra+Strength+Caplets+225+Count+Distributed+In+The+U.S.&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FSafety%2FRecalls%2Fucm261498.htm%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.law.du.edu/documents/corporate-governance/independent-director/johnsonjohnson/Opinion-In-re-Johnson-and-Johnson-10-cv-2033-D-NJ-Sept-29-2011.PDF">"10-cv-2033, D. NJ., Sept. 29, 2011"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=10-cv-2033%2C+D.+NJ.%2C+Sept.+29%2C+2011&amp;rft_id=http%3A%2F%2Fwww.law.du.edu%2Fdocuments%2Fcorporate-governance%2Findependent-director%2Fjohnsonjohnson%2FOpinion-In-re-Johnson-and-Johnson-10-cv-2033-D-NJ-Sept-29-2011.PDF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.boston.com/business/healthcare/2012/07/12/shareholders-reach-tentative-deal-lawsuit/6wGyy1rFpcVUR6OEdvYPTL/story.html">J&amp;J, shareholders reach tentative deal in lawsuit</a> By Linda A. Johnson, AP Business Writer / July 12, 2012</span>
</li>
<li id="cite_note-CNNMoney-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-CNNMoney_113-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Gregory Wallace (November 4, 2013). <a rel="nofollow" class="external text" href="http://money.cnn.com/2013/11/04/news/companies/johnson-and-johnson-settlement/">"Johnson &amp; Johnson to pay $2 billion for false marketing"</a>. <i>CNN Money</i><span class="reference-accessdate">. Retrieved <span class="nowrap">November 6,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNN+Money&amp;rft.atitle=Johnson+%26+Johnson+to+pay+%242+billion+for+false+marketing&amp;rft.date=2013-11-04&amp;rft.au=Gregory+Wallace&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F2013%2F11%2F04%2Fnews%2Fcompanies%2Fjohnson-and-johnson-settlement%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2012/04/12/business/drug-giant-is-fined-1-2-billion-in-arkansas.html?_r=0">J.&amp;J. Fined $1.2 Billion in Drug Case</a> NY Times, By KATIE THOMAS Published: April 11, 2012</span>
</li>
<li id="cite_note-Hilzenrath-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hilzenrath_115-0">^</a></b></span> <span class="reference-text"><cite class="citation news">Hilzenrath, David S. (January 16, 2010). <a rel="nofollow" class="external text" href="https://www.washingtonpost.com/wp-dyn/content/article/2010/01/15/AR2010011503903.html">"Justice suit accuses Johnson &amp; Johnson of paying kickbacks"</a>. <i>The Washington Post</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 17,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=Justice+suit+accuses+Johnson+%26+Johnson+of+paying+kickbacks&amp;rft.date=2010-01-16&amp;rft.au=Hilzenrath%2C+David+S.&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2010%2F01%2F15%2FAR2010011503903.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><cite class="citation news">Singer, Natasha (January 15, 2010). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2010/01/16/business/16drug.html">"Johnson &amp; Johnson Accused of Drug Kickbacks"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 17,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Johnson+%26+Johnson+Accused+of+Drug+Kickbacks&amp;rft.date=2010-01-15&amp;rft.au=Singer%2C+Natasha&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F01%2F16%2Fbusiness%2F16drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2012-06-11/j-j-said-to-pay-2-2-billion-to-end-risperdal-sales-probe.html">J&amp;J Said to Agree to $2.2 Billion Drug Marketing Accord</a> Bloomberg News. By Margaret Cronin Fisk, Jef Feeley &amp; David Voreacos – June 11, 2012</span>
</li>
<li id="cite_note-DOH2013-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-DOH2013_118-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Office of Public Affairs, Department of Justice (November 4, 2015). <a rel="nofollow" class="external text" href="https://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations">"Johnson &amp; Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations"</a>. United States Department of Justice<span class="reference-accessdate">. Retrieved <span class="nowrap">June 16,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+%26+Johnson+to+Pay+More+Than+%242.2+Billion+to+Resolve+Criminal+and+Civil+Investigations&amp;rft.pub=United+States+Department+of+Justice&amp;rft.date=2015-11-04&amp;rft.aulast=Office+of+Public+Affairs&amp;rft.aufirst=Department+of+Justice&amp;rft_id=http%3A%2F%2Fwww.justice.gov%2Fopa%2Fpr%2Fjohnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/11/25/health/25psych.html">Research Center Tied to Drug Company</a> By Gardiner Harris, The New York Times, 2008</span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/litigation/litreleases/2011/lr21922.htm">"Johnson &amp; Johnson"</a>. <i>www.sec.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 5,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.sec.gov&amp;rft.atitle=Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2Flitigation%2Flitreleases%2F2011%2Flr21922.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-jj-bribery-idUSTRE7374ZB20110408">"J&amp;J settles U.S., UK bribery, kickback charges"</a>. <i>Reuters</i>. April 8, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">July 5,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=J%26J+settles+U.S.%2C+UK+bribery%2C+kickback+charges&amp;rft.date=2011-04-08&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-jj-bribery-idUSTRE7374ZB20110408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-FCPA2011-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-FCPA2011_122-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.sec.gov/news/press/2011/2011-87.htm">"SEC Charges Johnson &amp; Johnson With Foreign Bribery"</a>. <i>SEC</i>. April 7, 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=SEC&amp;rft.atitle=SEC+Charges+Johnson+%26+Johnson+With+Foreign+Bribery&amp;rft.date=2011-04-07&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2Fnews%2Fpress%2F2011%2F2011-87.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.drugwatch.com/2017/05/26/jj-33-million-settlement-states/">"J&amp;J Reaches $33 Million Settlement with States"</a>. <i>DrugWatch</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 5,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=DrugWatch&amp;rft.atitle=J%26J+Reaches+%2433+Million+Settlement+with+States&amp;rft_id=https%3A%2F%2Fwww.drugwatch.com%2F2017%2F05%2F26%2Fjj-33-million-settlement-states%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><cite class="citation news">Reuters (May 24, 2017). <a rel="nofollow" class="external text" href="http://economictimes.indiatimes.com/news/international/business/johnson-johnson-settles-drug-manufacturing-probe-by-us-states-for-33-million/articleshow/58829546.cms">"Johnson &amp; Johnson settles drug manufacturing probe by US states for $33 million"</a>. <i>The Economic Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 5,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Economic+Times&amp;rft.atitle=Johnson+%26+Johnson+settles+drug+manufacturing+probe+by+US+states+for+%2433+million&amp;rft.date=2017-05-24&amp;rft.au=Reuters&amp;rft_id=http%3A%2F%2Feconomictimes.indiatimes.com%2Fnews%2Finternational%2Fbusiness%2Fjohnson-johnson-settles-drug-manufacturing-probe-by-us-states-for-33-million%2Farticleshow%2F58829546.cms&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title=" Dead link since July 2018">permanent dead link</span></a></i>]</span></sup></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.businessinsider.com/r-update-1-jj-settles-drug-manufacturing-probe-by-us-states-for-33-mln-2017-5">"UPDATE 1-J&amp;J settles drug manufacturing probe by U.S. states for $33 mln"</a>. <i>Business Insider</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 5,</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider&amp;rft.atitle=UPDATE+1-J%26J+settles+drug+manufacturing+probe+by+U.S.+states+for+%2433+mln&amp;rft_id=http%3A%2F%2Fwww.businessinsider.com%2Fr-update-1-jj-settles-drug-manufacturing-probe-by-us-states-for-33-mln-2017-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://tarr.uspto.gov/servlet/tarr?regser=serial&amp;entry=71013666">"Trademark Status &amp; Document Retrieval"</a>. <i>uspto.gov</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=uspto.gov&amp;rft.atitle=Trademark+Status+%26+Document+Retrieval&amp;rft_id=http%3A%2F%2Ftarr.uspto.gov%2Fservlet%2Ftarr%3Fregser%3Dserial%26entry%3D71013666&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.icrc.org/ihl.nsf/NORM/D6B53F5B5D14F35AC1256402003F9920?OpenDocument">U.S. reservations to the 1949 Geneva Conventions</a> (<a href="/wiki/International_Committee_of_the_Red_Cross" title="International Committee of the Red Cross">International Committee of the Red Cross</a> website)</span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.redcross.org/pressrelease/0,1077,0_314_6910,00.html">American Red Cross Defends Use of Emblem and Mission</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20070818044717/http://www.redcross.org/pressrelease/0,1077,0_314_6910,00.html#">Archived</a> August 18, 2007, at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a> (<a href="/wiki/American_Red_Cross" title="American Red Cross">American Red Cross</a> press release, August 10, 2007)</span>
</li>
<li id="cite_note-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-129">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB118662527980592590">"Red Cross Is Sued by J&amp;J Over Signature Emblem"</a> <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i> August 9, 2007</span>
</li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text"><cite class="citation news"><a href="/wiki/Stephanie_Saul" title="Stephanie Saul">Saul, Stephanie</a> (June 18, 2008). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/06/18/business/18cross.html">"Claim Over Red Cross Symbol Is Settled"</a>. <i>The New York Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Claim+Over+Red+Cross+Symbol+Is+Settled&amp;rft.date=2008-06-18&amp;rft.aulast=Saul&amp;rft.aufirst=Stephanie&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2008%2F06%2F18%2Fbusiness%2F18cross.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.wsj.com/articles/SB10001424052748704107204575039430685168478">Boston Scientific to Pay J&amp;J $1.73B to Settle Stent Patent Disputes</a>, <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>, February 2, 2010</span>
</li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/2014/11/19/us-johnson-johnson-boston-scient-trial-idUSKCN0J30CS20141119">J&amp;J seeks over $5 billion in damages from Boston Scientific at trial</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>, 19 November 2014</span>
</li>
<li id="cite_note-Bloomberg2009-133"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bloomberg2009_133-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bloomberg2009_133-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/apps/news?pid=newsarchive&amp;sid=aF0Qoxe0JCiw">Abbott Told to Pay Record $1.67 billion Award to J&amp;J</a>, <i>Bloomberg News</i>, June 29, 2009</span>
</li>
<li id="cite_note-bloomberg2010-134"><span class="mw-cite-backlink">^ <a href="#cite_ref-bloomberg2010_134-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bloomberg2010_134-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2010-11-02/abbott-challenges-1-67-billion-patent-loss-to-j-j-over-arthritis-therapy.html">Abbott Challenges $1.67 billion Patent Loss to J&amp;J Over Humira</a>, <i>Bloomberg News</i>, November 2, 2010</span>
</li>
<li id="cite_note-WSJ2013-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-WSJ2013_135-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://online.wsj.com/news/articles/SB10001424127887324188604578541080995659790">Pfizer, Takeda to Get $2.15 Billion Settlement</a>, <i>WSJ</i>, 6 12 2013</span>
</li>
<li id="cite_note-BusinessWeek2011-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-BusinessWeek2011_136-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110506001424/http://www.businessweek.com/news/2011-02-23/abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory.html">"abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory"</a>. <i>Bloomberg.com</i>. Archived from <a rel="nofollow" class="external text" href="http://www.businessweek.com/news/2011-02-23/abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory.html">the original</a> on May 6, 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Bloomberg.com&amp;rft.atitle=abbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory&amp;rft_id=http%3A%2F%2Fwww.businessweek.com%2Fnews%2F2011-02-23%2Fabbott-wins-reversal-of-j-j-s-1-67-billion-patent-victory.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-cbsnews.com-137"><span class="mw-cite-backlink">^ <a href="#cite_ref-cbsnews.com_137-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cbsnews.com_137-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.cbsnews.com/news/states-file-lawsuit-against-johnson-johnson-over-pelvic-mesh-implants/">"States file lawsuit against Johnson &amp; Johnson over pelvic mesh implants"</a>. <i>www.cbsnews.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cbsnews.com&amp;rft.atitle=States+file+lawsuit+against+Johnson+%26+Johnson+over+pelvic+mesh+implants&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fstates-file-lawsuit-against-johnson-johnson-over-pelvic-mesh-implants%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><cite class="citation web">Knaus, Christopher (July 4, 2017). <a rel="nofollow" class="external text" href="https://www.theguardian.com/australia-news/2017/jul/04/vaginal-mesh-risks-downplayed-by-johnson-johnson-court-told">"Vaginal mesh risks downplayed by Johnson &amp; Johnson, court told"</a>. <i>the Guardian</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=the+Guardian&amp;rft.atitle=Vaginal+mesh+risks+downplayed+by+Johnson+%26+Johnson%2C+court+told&amp;rft.date=2017-07-04&amp;rft.aulast=Knaus&amp;rft.aufirst=Christopher&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Faustralia-news%2F2017%2Fjul%2F04%2Fvaginal-mesh-risks-downplayed-by-johnson-johnson-court-told&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><cite class="citation news">Devlin, Hannah (November 27, 2018). <a rel="nofollow" class="external text" href="https://www.theguardian.com/society/2018/nov/27/vaginal-mesh-implant-sold-despite-warnings-could-cause-pain-johnson-johnson">"Pharma giant sold mesh implant despite pain warnings"</a>. <i>The Guardian</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0261-3077">0261-3077</a><span class="reference-accessdate">. Retrieved <span class="nowrap">November 25,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Pharma+giant+sold+mesh+implant+despite+pain+warnings&amp;rft.date=2018-11-27&amp;rft.issn=0261-3077&amp;rft.aulast=Devlin&amp;rft.aufirst=Hannah&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2018%2Fnov%2F27%2Fvaginal-mesh-implant-sold-despite-warnings-could-cause-pain-johnson-johnson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><cite class="citation news">Sebastian, Dave (October 17, 2019). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/johnson-johnson-to-pay-117-million-over-surgical-device-marketing-11571334613">"Johnson &amp; Johnson to Pay $117 Million Over Surgical Device Marketing"</a>. <i>Wall Street Journal</i>. New York NY: Dow Jones and Company.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Johnson+%26+Johnson+to+Pay+%24117+Million+Over+Surgical+Device+Marketing&amp;rft.date=2019-10-17&amp;rft.aulast=Sebastian&amp;rft.aufirst=Dave&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fjohnson-johnson-to-pay-117-million-over-surgical-device-marketing-11571334613&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-BBC-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-BBC_141-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.bbc.co.uk/news/world-us-canada-35648252">"Johnson &amp; Johnson hit with $72m damages in talc-cancer case"</a>. <i>BBC News</i>. February 24, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">February 24,</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Johnson+%26+Johnson+hit+with+%2472m+damages+in+talc-cancer+case&amp;rft.date=2016-02-24&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fworld-us-canada-35648252&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://www.bloomberg.com/features/2016-baby-powder-cancer-lawsuits/">Johnson &amp; Johnson Has a Baby Powder Problem</a> Bloomberg, Retrieved April 20, 2017.</span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit/jj-ordered-to-pay-417-million-in-trial-over-talc-cancer-risks-idUSKCN1B121D">"J&amp;J ordered to pay $417 million in trial over talc cancer risks"</a>. August 21, 2017 – via Reuters.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=J%26J+ordered+to+pay+%24417+million+in+trial+over+talc+cancer+risks&amp;rft.date=2017-08-21&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-johnson-johnson-cancer-lawsuit%2Fjj-ordered-to-pay-417-million-in-trial-over-talc-cancer-risks-idUSKCN1B121D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><cite class="citation web">Currier, Joel. <a rel="nofollow" class="external text" href="http://www.stltoday.com/news/local/crime-and-courts/missouri-appeals-court-tosses-out-million-dollar-johnson-johnson-talcum/article_e976d9eb-c9dc-5fdf-b136-8d94bc6cfbdd.html">"Missouri appeals court tosses out $72 million Johnson &amp; Johnson talcum powder verdict"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Missouri+appeals+court+tosses+out+%2472+million+Johnson+%26+Johnson+talcum+powder+verdict&amp;rft.aulast=Currier&amp;rft.aufirst=Joel&amp;rft_id=http%3A%2F%2Fwww.stltoday.com%2Fnews%2Flocal%2Fcrime-and-courts%2Fmissouri-appeals-court-tosses-out-million-dollar-johnson-johnson-talcum%2Farticle_e976d9eb-c9dc-5fdf-b136-8d94bc6cfbdd.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><cite class="citation web">Bever, Lindsey (July 13, 2018). <a rel="nofollow" class="external text" href="https://www.washingtonpost.com/news/to-your-health/wp/2018/07/13/johnson-johnson-ordered-to-pay-4-7-billion-to-women-who-say-baby-powder-gave-them-cancer/">"Johnson &amp; Johnson ordered to pay $4.7 billion to women who say baby powder gave them cancer"</a>. <i><a href="/wiki/Washington_Post" class="mw-redirect" title="Washington Post">Washington Post</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 28,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Washington+Post&amp;rft.atitle=Johnson+%26+Johnson+ordered+to+pay+%244.7+billion+to+women+who+say+baby+powder+gave+them+cancer&amp;rft.date=2018-07-13&amp;rft.aulast=Bever&amp;rft.aufirst=Lindsey&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fnews%2Fto-your-health%2Fwp%2F2018%2F07%2F13%2Fjohnson-johnson-ordered-to-pay-4-7-billion-to-women-who-say-baby-powder-gave-them-cancer%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-146">^</a></b></span> <span class="reference-text"><cite class="citation news">Salter, Jim (December 23, 2019). <a rel="nofollow" class="external text" href="https://www.seattletimes.com/business/st-louis-jury-sides-with-johnson-johnson-in-talc-case/">"St. Louis jury sides with Johnson &amp; Johnson in talc case"</a>. <i>The Seattle Times</i>. Associated Press<span class="reference-accessdate">. Retrieved <span class="nowrap">December 24,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=St.+Louis+jury+sides+with+Johnson+%26+Johnson+in+talc+case&amp;rft.date=2019-12-23&amp;rft.aulast=Salter&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.seattletimes.com%2Fbusiness%2Fst-louis-jury-sides-with-johnson-johnson-in-talc-case%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-147">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.aljazeera.com/ajimpact/johnson-johnson-ceo-refuses-attend-hearing-carcinogens-191210004346338.html">"Johnson &amp; Johnson CEO refuses to attend US hearing on carcinogens"</a>. <i>www.aljazeera.com</i>. December 10, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">December 11,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.aljazeera.com&amp;rft.atitle=Johnson+%26+Johnson+CEO+refuses+to+attend+US+hearing+on+carcinogens&amp;rft.date=2019-12-10&amp;rft_id=https%3A%2F%2Fwww.aljazeera.com%2Fajimpact%2Fjohnson-johnson-ceo-refuses-attend-hearing-carcinogens-191210004346338.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.livemint.com/Companies/f2z1TqJx9HtNRwmAEiIXXK/Johnson-and-Johnsonremoveschemicals-to-make-products-safer.html">"Johnson and Johnson removes chemicals to make products safer"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 25,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johnson+and+Johnson+removes+chemicals+to+make+products+safer&amp;rft_id=https%3A%2F%2Fwww.livemint.com%2FCompanies%2Ff2z1TqJx9HtNRwmAEiIXXK%2FJohnson-and-Johnsonremoveschemicals-to-make-products-safer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-149">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.nbcnews.com/health/health-news/johnson-johnson-knew-decades-asbestos-lurked-its-baby-powder-n948016">"Johnson &amp; Johnson knew for decades that asbestos lurked in some of its baby powder"</a>. <i>NBC News</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NBC+News&amp;rft.atitle=Johnson+%26+Johnson+knew+for+decades+that+asbestos+lurked+in+some+of+its+baby+powder&amp;rft_id=https%3A%2F%2Fwww.nbcnews.com%2Fhealth%2Fhealth-news%2Fjohnson-johnson-knew-decades-asbestos-lurked-its-baby-powder-n948016&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-150">^</a></b></span> <span class="reference-text"><cite class="citation web">Scipioni, Jade (December 19, 2018). <a rel="nofollow" class="external text" href="https://www.foxbusiness.com/features/jj-loses-its-battle-to-overturn-a-4-7b-baby-power-verdict">"J&amp;J loses its battle to overturn a $4.7B baby powder verdict"</a>. <i>FOXBusiness</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 19,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FOXBusiness&amp;rft.atitle=J%26J+loses+its+battle+to+overturn+a+%244.7B+baby+powder+verdict&amp;rft.date=2018-12-19&amp;rft.aulast=Scipioni&amp;rft.aufirst=Jade&amp;rft_id=https%3A%2F%2Fwww.foxbusiness.com%2Ffeatures%2Fjj-loses-its-battle-to-overturn-a-4-7b-baby-power-verdict&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-151">^</a></b></span> <span class="reference-text"><cite class="citation web"><a href="/wiki/Steven_Novella" title="Steven Novella">Steven Novella</a>. <a rel="nofollow" class="external text" href="https://theness.com/neurologicablog/index.php/the-johnson-and-johnson-talc-cancer-case/">"The Johnson and Johnson Talc Cancer Case"</a>. <i>Neurologica blog</i><span class="reference-accessdate">. Retrieved <span class="nowrap">September 30,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Neurologica+blog&amp;rft.atitle=The+Johnson+and+Johnson+Talc+Cancer+Case&amp;rft.au=Steven+Novella&amp;rft_id=https%3A%2F%2Ftheness.com%2Fneurologicablog%2Findex.php%2Fthe-johnson-and-johnson-talc-cancer-case%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-152">^</a></b></span> <span class="reference-text"><cite class="citation news">Gurman, Sadie; Mulvihill, Geoff (March 2, 2018). <a rel="nofollow" class="external text" href="https://www.dddmag.com/news/2018/03/doj-support-lawsuits-against-companies-selling-opioids">"DOJ to Support Lawsuits Against Companies Selling Opioids"</a>. <i>Drug Discovery &amp; Development</i>. Advantage Business Media. Associated Press<span class="reference-accessdate">. Retrieved <span class="nowrap">March 2,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Discovery+%26+Development&amp;rft.atitle=DOJ+to+Support+Lawsuits+Against+Companies+Selling+Opioids&amp;rft.date=2018-03-02&amp;rft.aulast=Gurman&amp;rft.aufirst=Sadie&amp;rft.au=Mulvihill%2C+Geoff&amp;rft_id=https%3A%2F%2Fwww.dddmag.com%2Fnews%2F2018%2F03%2Fdoj-support-lawsuits-against-companies-selling-opioids&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.cnn.com/2019/03/12/health/oklahoma-opioid-trial-johnson-and-johnson-kingpin/index.html">"Johnson &amp; Johnson acted as opioid kingpin, Oklahoma attorney general says"</a>. CNN. March 12, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">March 14,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Johnson+%26+Johnson+acted+as+opioid+kingpin%2C+Oklahoma+attorney+general+says&amp;rft.date=2019-03-12&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2019%2F03%2F12%2Fhealth%2Foklahoma-opioid-trial-johnson-and-johnson-kingpin%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-154">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://seekingalpha.com/article/4200206-trump-insurance-johnson-and-johnson">"Trump Insurance For Johnson &amp; Johnson"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 25,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Trump+Insurance+For+Johnson+%26+Johnson&amp;rft_id=https%3A%2F%2Fseekingalpha.com%2Farticle%2F4200206-trump-insurance-johnson-and-johnson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-155"><span class="mw-cite-backlink"><b><a href="#cite_ref-155">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.idahostatesman.com/living/health-fitness/article216893150.html">"11 Idaho counties take on Walmart, CVS, drug companies in opioid lawsuit"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">August 25,</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=11+Idaho+counties+take+on+Walmart%2C+CVS%2C+drug+companies+in+opioid+lawsuit&amp;rft_id=https%3A%2F%2Fwww.idahostatesman.com%2Fliving%2Fhealth-fitness%2Farticle216893150.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-156">^</a></b></span> <span class="reference-text"><cite class="citation news">Randazzo, Sara (May 27, 2019). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/first-big-trial-in-opioid-crisis-set-to-kick-off-in-oklahoma-11558958401">"First Big Trial in Opioid Crisis Set to Kick Off in Oklahoma"</a>. <i>Wall Street Journal</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0099-9660">0099-9660</a><span class="reference-accessdate">. Retrieved <span class="nowrap">May 28,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=First+Big+Trial+in+Opioid+Crisis+Set+to+Kick+Off+in+Oklahoma&amp;rft.date=2019-05-27&amp;rft.issn=0099-9660&amp;rft.aulast=Randazzo&amp;rft.aufirst=Sara&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Ffirst-big-trial-in-opioid-crisis-set-to-kick-off-in-oklahoma-11558958401&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><cite class="citation web">Howard, Jacqueline; Drash, Wayne (August 26, 2019). <a rel="nofollow" class="external text" href="https://www.cnn.com/2019/08/26/health/oklahoma-opioid-trial-verdict-bn/index.html">"Oklahoma wins case against drugmaker in historic opioid trial"</a>. <i><a href="/wiki/CNN" title="CNN">CNN</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 26,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNN&amp;rft.atitle=Oklahoma+wins+case+against+drugmaker+in+historic+opioid+trial&amp;rft.date=2019-08-26&amp;rft.aulast=Howard&amp;rft.aufirst=Jacqueline&amp;rft.au=Drash%2C+Wayne&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2019%2F08%2F26%2Fhealth%2Foklahoma-opioid-trial-verdict-bn%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.usnews.com/news/healthiest-communities/articles/2019-10-02/johnson-and-johnson-agrees-to-pay-ohio-counties-204m-opioid-settlement">"Johnson &amp; Johnson to Pay Ohio Counties $20.4M Opioid Settlement"</a>. <i>www.usnews.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.usnews.com&amp;rft.atitle=Johnson+%26+Johnson+to+Pay+Ohio+Counties+%2420.4M+Opioid+Settlement&amp;rft_id=https%3A%2F%2Fwww.usnews.com%2Fnews%2Fhealthiest-communities%2Farticles%2F2019-10-02%2Fjohnson-and-johnson-agrees-to-pay-ohio-counties-204m-opioid-settlement&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-159"><span class="mw-cite-backlink"><b><a href="#cite_ref-159">^</a></b></span> <span class="reference-text"><cite class="citation news">Randazzo, Sara (October 1, 2019). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/johnson-johnson-agrees-to-settle-ohio-opioid-lawsuits-for-20-4-million-11569977306?mod=article_inline">"Johnson &amp; Johnson Agrees to Settle Ohio Opioid Lawsuits for $20.4 Million"</a>. <i>Wall Street Journal</i>. New York NY: Dow Jones and Company.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Johnson+%26+Johnson+Agrees+to+Settle+Ohio+Opioid+Lawsuits+for+%2420.4+Million&amp;rft.date=2019-10-01&amp;rft.aulast=Randazzo&amp;rft.aufirst=Sara&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fjohnson-johnson-agrees-to-settle-ohio-opioid-lawsuits-for-20-4-million-11569977306%3Fmod%3Darticle_inline&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AJohnson+%26+Johnson" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(11)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Johnson_%26_Johnson&amp;action=edit&amp;section=42" title="Edit section: External links" data-section="42" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-11 collapsible-block" id="mf-section-11">
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Johnson_%26_Johnson" class="extiw" title="commons:Category:Johnson &amp; Johnson"><span style="">Johnson &amp; Johnson</span></a></b></i>.</td></tr></tbody></table><ul><li><span class="official-website"><span class="url"><a rel="nofollow" class="external text" href="http://www.jnj.com">Official website</a></span></span></li></ul><ul><li>Business data for Johnson &amp; Johnson: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=JNJ">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=JNJ">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=200406">SEC filings</a></li></ul></div></li></ul>



<p><span style="font-size: small;"><span id="coordinates"><a href="/wiki/Geographic_coordinate_system" title="Geographic coordinate system">Coordinates</a>: <span class="plainlinks nourlexpansion"><a class="external text" href="//tools.wmflabs.org/geohack/geohack.php?pagename=Johnson_%26_Johnson&amp;params=40_29_55_N_74_26_37_W_type:landmark_region:US-NJ"><span class="geo-default"><span class="geo-dms" title="Maps, aerial photos, and other data for this location"><span class="latitude">40°29′55″N</span> <span class="longitude">74°26′37″W</span></span></span><span class="geo-multi-punct">﻿ / ﻿</span><span class="geo-nondefault"><span class="geo-dec" title="Maps, aerial photos, and other data for this location">40.49861°N 74.44361°W</span><span style="display:none">﻿ / <span class="geo">40.49861; -74.44361</span></span></span></a></span></span></span>
</p>





</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Johnson_%26_Johnson&amp;oldid=950813906">https://en.wikipedia.org/w/index.php?title=Johnson_%26_Johnson&amp;oldid=950813906</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Johnson_%26_Johnson"
				data-user-name="OAbot"
				data-user-gender="unknown"
				data-timestamp="1586822818">
				<span>Last edited on 14 April 2020, at 00:06</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Johnson_%26_Johnson&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.632","walltime":"2.066","ppvisitednodes":{"value":9121,"limit":1000000},"postexpandincludesize":{"value":331198,"limit":2097152},"templateargumentsize":{"value":14177,"limit":2097152},"expansiondepth":{"value":18,"limit":40},"expensivefunctioncount":{"value":17,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":436554,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 1803.143      1 -total"," 51.55%  929.571      1 Template:Reflist"," 28.45%  513.069    102 Template:Cite_web"," 15.03%  270.976      1 Template:Infobox_company"," 14.23%  256.645      1 Template:Infobox","  7.82%  140.960      4 Template:Wikidata","  6.80%  122.612     26 Template:Cite_news","  6.68%  120.393     14 Template:Fix","  4.92%   88.667      5 Template:Cite_journal","  4.42%   79.780     11 Template:Citation_needed"]},"scribunto":{"limitreport-timeusage":{"value":"0.886","limit":"10.000"},"limitreport-memusage":{"value":10700922,"limit":52428800}},"cachereport":{"origin":"mw1325","timestamp":"20200416051034","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Johnson & Johnson","url":"https:\/\/en.wikipedia.org\/wiki\/Johnson_%26_Johnson","sameAs":"http:\/\/www.wikidata.org\/entity\/Q333718","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q333718","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2003-01-08T09:50:36Z","dateModified":"2020-04-14T00:06:58Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/9\/99\/JohnsonJohnson_HQ_building.jpg","headline":"U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":201,"wgHostname":"mw1354"});});</script>		</body>
		</html>
		